NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1: Organization and Basis of Presentation
Semtech Corporation (together with its consolidated subsidiaries, the "Company" or "Semtech") is a leading provider of high-performance semiconductor, Internet of Things ("IoT") systems and cloud connectivity service solutions. The end customers for the Company’s silicon solutions are primarily original equipment manufacturers ("OEMs") that produce and sell technology solutions. The Company’s IoT module, router, gateway and managed connectivity solutions ship to IoT device makers and enterprises to provide IoT connectivity to end devices.
The Company designs, develops, manufactures and markets a diverse portfolio of products for commercial applications, addressing the global infrastructure, high-end consumer and industrial end markets.
Basis of Presentation
The Company reports results on the basis of 52 and 53-week periods and ends its fiscal year on the last Sunday in January. Fiscal years 2026, 2025 and 2024 each consisted of 52 weeks. Fiscal year 2027 will consist of 53 weeks.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). The Company’s Consolidated Statements of Operations are referred to herein as the "Statements of Operations," the Company’s Consolidated Balance Sheets are referred to herein as the "Balance Sheets" and the Company's Consolidated Statements of Cash Flows are referred to herein as the "Statements of Cash Flows." The Company consolidates entities that are not variable interest entities ("VIEs") when it owns, directly or indirectly, a majority interest in the entity or is otherwise able to control the entity. The Company consolidates VIEs in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 810, "Consolidation." Entities for which the Company owns an interest, but does not consolidate, are accounted for under the equity method or cost method of accounting as minority investments and are included in "Other Assets" within the Balance Sheets. The ownership interest in a consolidated subsidiary of the Company held by outside parties is included in "Noncontrolling Interest" within the Balance Sheets.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Note 2: Significant Accounting Policies
Cash and Cash Equivalents
The Company considers all highly-liquid investments with an original maturity of 90 days or less and money market mutual funds to be cash equivalents. At various times, such amounts are in excess of insured limits. Cash equivalents can consist of money market mutual funds, government and corporate obligations, and bank time deposits.
Investments
The Company’s investment policy restricts investments to high credit quality investments with limits on the length to maturity and requires diversification of investment portfolio. These investments, especially corporate obligations, are subject to default risk. The Company classifies its convertible debt investments as available-for-sale ("AFS") securities and reports these investments at fair value with current and long-term AFS investments included in "Other current assets" and "Other assets," respectively, in the Balance Sheets. Unrealized gains or losses, net of tax, are recorded in "Accumulated other comprehensive loss" in the Balance Sheets, and realized gains or losses, as well as current expected credit loss reserves are recorded in "Non-operating income, net" in the Statements of Operations.
The Company has minority equity investments in privately-held companies that are classified in "Other assets" in the Balance Sheets. Substantially all of these investments are carried at cost because the Company does not have readily determinable fair values or because the Company does not have the ability to exercise significant influence over the companies. The Company has determined that it is not practicable to estimate the fair values of these investments and accounts for them at cost in accordance with ASC 321–Investments. As of January 25, 2026 and January 26, 2025, the Company had aggregate net investments carried at cost of $31.7 million and $33.4 million, respectively. As of January 25, 2026 and January 26, 2025, aggregate net investments accounted for under the equity method of accounting totaled $5.3 million and $5.7 million, respectively. The Company monitors whether there have been any events or changes in circumstances that would have a significant adverse effect on the fair values of these investments and recognizes losses in the Statements of Operations when it determines that declines in the fair values of its investments below their cost are other than temporary. The Company recorded investment impairments and credit loss reserves, net of $10.4 million, $1.1 million and $3.9 million during fiscal years 2026, 2025 and 2024, respectively.
Accounts Receivable Allowances
Accounts receivable are trade-related receivables recorded at net realizable value or the amount that the Company expects to collect on gross customer trade receivables. The Company evaluates the collectability of its accounts receivable based on a combination of factors. Historically, bad debt provisions have been consistent with management’s expectations. If the Company becomes aware of a customer’s inability to meet its financial obligations after a sale has occurred, it records an allowance to reduce the net receivable to the amount it reasonably believes it will be able to collect from the customer. For all other customers, the Company recognizes allowances for doubtful accounts based on the length of time the receivables are past due, the current business environment and historical experience. If the financial condition of the Company’s customers were to deteriorate or if economic conditions worsen, additional allowances may be required in the future.
Inventories
Inventories are stated at lower of cost or net realizable value and consist of materials, labor, and overhead. The Company determines the cost of inventory by the first-in, first-out method. The Company evaluates inventories for excess quantities and obsolescence. This evaluation includes analysis of sales levels by product and projections of future demand. If future demand or market conditions are less favorable than the Company’s projections, a write-down of inventory may be required, and would be reflected in cost of goods sold in the period the write down is made. In order to state the inventory at lower of cost or net realizable value, the Company maintains reserves against inventory to write down its inventory.
Business Combinations
The Company accounts for business combinations in accordance with ASC 805, "Business Combinations." The Company allocates the purchase price paid for assets acquired and liabilities assumed in connection with acquisitions based on their estimated fair values at the time of acquisition. This allocation involves a number of assumptions, estimates and judgments that could materially affect the timing or amounts recognized in its financial statements. The most subjective areas include determining the fair values of the following:
•intangible assets, including the valuation methodology, estimations of future cash flows, discount rates, market segment growth rates and the Company's assumed market segment share, as well as the estimated useful life of intangible assets;
•deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date;
•inventory; property, plant and equipment; pre-existing liabilities or legal claims; deferred revenue; and contingent consideration, each as may be applicable; and
•goodwill as measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed.
The Company’s assumptions and estimates are based upon comparable market data and information obtained from management and the management of the acquired companies. The Company allocates goodwill to the reporting units of the business that are expected to benefit from the business combination.
Variable Interest Entities
The Company consolidates VIEs in accordance with ASC 810, "Consolidation," if it is the primary beneficiary of the VIE, which is determined if it has a controlling financial interest in the VIE. A controlling financial interest will have both of the following characteristics: (i) the power to direct the VIE's activities that most significantly impact the VIE's economic performance and (ii) the obligation to absorb the VIE's losses that could potentially be significant to the VIE or the right to receive the VIE's benefits that could potentially be significant to the VIE.
The Company’s variable interests in VIEs may be in the form of equity ownership, contracts to purchase assets, management services, and development agreements between the Company and a VIE, loans provided by the Company to a VIE or other member, and/or guarantees provided by members to banks and other parties.
The Company analyzes its investments or other interests to determine whether it represents a variable interest in a VIE. If so, the Company evaluates the facts to determine whether it is the primary beneficiary, based on if it has a controlling financial interest in the VIE. The Company concluded that some of its equity interests represent a variable interest, but it is not the primary beneficiary as prescribed in ASC 810. Specifically, in reaching this conclusion, the Company considered the activities that most significantly drive profitability for these private entities and determined that the activities that most significantly drive profitability are related to the technology and related product road maps. In some cases, the Company has a board observer role, however, it concluded that in these cases it was not in a position of decision-making or other authority to influence the activities of the private entities that could be considered significant with respect to their operations, including research and development plans and changes to their product road maps.
Derivatives and Hedging Activities
The Company records all derivatives on the Balance Sheets at fair value in accordance with ASC 815, "Derivatives and Hedging" (other than the Convertible Note Hedges and the Warrants, which are recorded in additional paid-in capital as described below). The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risks, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Convertible Note Hedges and the Warrants meet certain accounting criteria under GAAP, are recorded in additional paid-in capital on the Balance Sheets, and are not accounted for as derivatives that are remeasured each reporting period.
In accordance with the FASB’s fair value measurement guidance, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Property, Plant and Equipment
Property, plant and equipment are stated at cost or at fair market value at the time of acquisition. Depreciation is computed over the estimated useful lives of the related asset type or term of the operating lease using the straight-line method for financial statement purposes. Maintenance and repairs are charged to expense as incurred and the costs of additions and betterments that increase the useful lives of the assets are capitalized.
Goodwill
The Company performs an annual impairment assessment of goodwill at the reporting unit level in the fourth quarter of each fiscal year, or more frequently if indicators of potential impairment exist. The analysis may include both qualitative and quantitative factors to assess the likelihood of an impairment. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments and debt.
Qualitative factors include industry and market considerations, overall financial performance and other relevant events and factors affecting the reporting unit. Additionally, as part of this assessment, the Company may perform a quantitative analysis to support the qualitative factors above by applying sensitivities to assumptions and inputs used in measuring a reporting unit’s fair value.
The Company’s quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit's fair value. Significant estimates include market segment growth rates, assumed market segment share, estimated costs and discount rates based on a reporting unit's weighted average cost of capital.
The Company tests the reasonableness of the inputs and outcomes of its discounted cash flow analysis against available market data. During fiscal years 2026, 2025 and 2024, the Company recorded $84.8 million, $7.5 million and $755.6 million of goodwill impairment, respectively. See Note 7, Goodwill and Intangible Assets, for further discussion of the Company's goodwill.
Other Intangibles and Long-lived Assets
Finite-lived intangible assets resulting from business acquisitions or technology licenses purchased are amortized on a straight-line basis over their estimated useful lives. The useful lives of acquisition-related intangible assets approximate the point where over 90% of realizable undiscounted cash flows for each intangible asset are recognized. The assigned useful lives are based upon the Company’s historical experience with similar technology and other intangible assets owned by the Company. The useful life of technology licenses is usually based on the term of the agreement.
Acquired in-process research and development ("IPR&D") projects, which represent projects that had not reached technological feasibility as of the date of acquisition, are recorded at fair value. Initially, these are classified as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of development, acquired IPR&D asset balances are transferred to finite-lived intangible assets and amortized over their useful lives. The asset balances relating to projects that are abandoned after acquisition are impaired and recorded in "Product development and engineering" ("R&D") expense in the Statements of Operations.
Capitalized development costs are recorded at cost. Upon completion of construction, they are placed in service and amortized over their useful lives.
The Company reviews indefinite-lived intangible assets for impairment on an annual basis in conjunction with goodwill or whenever events or changes in circumstances indicate that the carrying value may exceed its fair value. Impairment of indefinite-lived intangible assets is measured by comparing the carrying amount of the asset to its fair value.
The Company assesses finite-lived intangibles and long-lived assets for impairment when indicators of impairment, such as reductions in demand or significant industry and economic slowdowns in the semiconductor and IoT industries, are present. Reviews are performed to determine whether the carrying value of an asset or asset group is impaired, based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value. During fiscal year 2026, the Company recorded $1.8 million of finite-lived intangibles impairment. No impairment of finite-lived intangibles was recorded in fiscal year 2025. During fiscal year 2024, in conjunction with the annual impairment assessment of goodwill, the Company recorded $131.4 million of finite-lived intangibles impairment.
For intangible long-lived assets, which consist of core technology and customer relationships, the Company uses the multi-period excess earnings method (an income approach) or the replacement cost method (a cost approach) to determine fair value. The multi-period excess earnings method estimates the value of the asset based on the present value of the after-tax cash flows attributable to the intangible asset, which includes the Company's estimates of forecasted revenue, operating margins, taxes, and discount rate. The replacement cost method incorporates a market participant’s assumption that an in-use premise is the highest and best use of customer relationships and core technology. The Company estimates the cost it would incur to rebuild or re-establish the intangible asset and the associated effort required to develop it.
The fair values of individual tangible long-lived assets are determined using the cost to reproduce the long-lived asset and taking into account the age, condition, inflation using the U.S. Bureau of Labor Statistics and Marshall Valuation Services, and cost to ready the long-lived asset for its intended use. Additionally, the Company considers the potential existence of functional and economic obsolescence and quantifies these elements in its cost approach as appropriate.
Functional Currency
The Company's reporting currency is the US dollar ("USD"). The Company determines the functional currency of each of its foreign subsidiaries and their operating divisions based on the primary currency in which they operate, which is either the USD or the local currency.
Revenue and expense items denominated in foreign currencies are translated at exchange rates prevailing during the period. When translating from the local currency to the functional currency, monetary assets and liabilities denominated in foreign currencies are translated at the period-end exchange rates, and non-monetary assets and liabilities are translated at exchange
rates in effect when the assets are acquired or the obligations are incurred. Foreign exchange gains and losses are reflected in net income for the period. The foreign exchange gains and losses arising from translation from the functional currency to the reporting currency are reported as a component of other comprehensive (loss) income.
Fair Value Measurements
When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. The Company uses the following three levels of inputs in determining the fair value of the Company’s assets and liabilities, focusing on the most observable inputs when available:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets or other inputs that are observable for the assets or liabilities, either directly or indirectly.
Level 3—Unobservable inputs based on the Company’s own assumptions, requiring significant management judgment or estimation.
To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement.
Revenue Recognition
The Company derives its revenue primarily from the sale of its products and services into various end markets. Recurring and other services revenue includes sales from cloud services, cellular connectivity services, managed connectivity and application services, software licenses, technical support services, extended warranty services, solution design and consulting services. Revenue is recognized in accordance with ASC 606, "Revenue from Contracts with Customers," when control of products is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for these products. Control is generally transferred when products are shipped and, to a lesser extent, when the products are delivered. Recovery of costs associated with product design and engineering services are recognized during the period in which services are performed and are reported as a reduction to product development and engineering expense. Historically, these recoveries have not exceeded the cost of the related development efforts. Recurring and other services revenue is recognized over time as the service is rendered or at a point in time upon completion of a service. The Company includes revenue related to granted technology licenses as part of "Net sales" in the Statements of Operations. Historically, revenue from these arrangements has not been significant though they are part of its recurring ordinary business.
The Company determines revenue recognition through the following five steps:
•Identification of the contract, or contracts, with a customer;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, performance obligations are satisfied.
The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.
The Company's customer contracts can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Net sales reflect the transaction prices for contracts, which include units shipped at selling prices reduced by variable consideration. Determination of variable consideration requires judgment by the Company. Variable consideration includes expected sales returns and other price adjustments. Variable consideration is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Sales returns are generally accepted at the Company’s discretion or from distributors with such rights. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration.
The Company provides an assurance type warranty, which is typically not sold separately and does not represent a separate performance obligation.
Contract Modifications: If a contract is modified, which does not normally occur, changes in contract specifications and requirements must be accounted for. The Company considers contract modifications to exist when the modification creates new, or changes existing, enforceable rights and obligations. Most of the Company’s contract modifications are to distributor agreements for adding new goods or services that are considered distinct from the existing contract and the change in contract price reflects the standalone selling price of the distinct service.
Disaggregated Revenue: The Company disaggregates revenue from contracts with customers by types of products and geography, as it believes it best depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. See Note 15, Segment Information, for further information on revenues by product line and geographic region.
Contract Balances: Accounts receivable represents the Company’s unconditional right to receive consideration from its customers. Contract assets consist of the Company’s right to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditioned on something other than the passage of time. The Company's contract asset balances were not material as of January 25, 2026 and January 26, 2025. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (i.e., receivable), before the entity transfers a good or service to the customer. The Company's deferred revenue contract liability balances are recorded in "Accrued liabilities" and "Other long term liabilities" in the Balance Sheets. The current portion of the Company's deferred revenue contract liability balances were $14.2 million and $15.9 million as of January 25, 2026 and January 26, 2025, respectively, and the long-term portion of the Company's deferred revenue contract liability balances were $11.7 million and $10.8 million as of January 25, 2026 and January 26, 2025, respectively. There were no impairment losses recognized on the Company’s accounts receivable or contract assets during the fiscal year ended January 25, 2026.
Contract Costs: All incremental customer contract acquisition costs are expensed as they are incurred as the amortization period of the asset that the Company otherwise would have recognized is one year or less in duration.
Significant Financing Component: The Company does not adjust the promised amount of consideration for the effects of a significant financing component. The expected timing difference between the payment and satisfaction of performance obligations for the vast majority of the Company’s contracts is one year or less; therefore, the Company applies a practical expedient and does not consider the effects of the time value of money. The Company’s contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive financing from the customers.
Sales and Value Added Tax Exclusion from the Transaction Price: The Company excludes from the measurement of the transaction price taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.
Shipping and Handling Activities: The Company accounts for shipping and handling activities performed after a customer obtains control of the good as activities to fulfill the promise to transfer the good.
Cost of Sales
Cost of sales includes materials, depreciation and impairments on fixed assets used in the manufacturing process, shipping costs, direct labor and overhead, as well as amortization of acquired technology and acquired technology impairments.
Sales and Marketing
The Company expenses sales and marketing costs, which include advertising costs, as they are incurred. Advertising costs were $1.4 million, $0.9 million and $1.5 million for fiscal years 2026, 2025 and 2024, respectively.
Product Development and Engineering
Product development and engineering costs are charged to expense as incurred. Recoveries from nonrecurring engineering services are recorded as an offset to product development expense incurred in support of this effort since these activities do not represent an earnings process core to the Company’s business and serve as a mechanism to partially recover development expenditures. The Company received approximately $4.6 million, $8.8 million and $5.4 million of recoveries for nonrecurring engineering services in fiscal years 2026, 2025 and 2024, respectively.
Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts and their respective tax bases. Current and long-term prepaid taxes are included in "Prepaid taxes" and "Other assets," respectively, and current and long-term liabilities for uncertain tax positions are included in "Accrued liabilities" and "Other long-term liabilities," respectively, in the Balance Sheets.
As part of the process of preparing the Company’s consolidated financial statements, the Company estimates income taxes in each of the jurisdictions in which it operates. This process involves estimating the current tax liability together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, it must establish a valuation allowance. To the extent the Company changes its valuation allowance in a period, the change is generally recorded through the tax provision in the Statements of Operations.
The Company continually reviews its position on undistributed earnings from its foreign subsidiaries to determine whether those earnings are indefinitely reinvested offshore. Domestic and foreign operating cash flow forecasts are reviewed to determine the sources and uses of cash. Based on these forecasts, the Company determines the need to accrue deferred tax liabilities associated with its undistributed offshore earnings.
Other Comprehensive (Loss) Income
Other comprehensive income or loss includes unrealized gains or losses on AFS investments, foreign currency and interest rate hedging activities, changes in defined benefit plans, and cumulative translation adjustment, which are presented in the Statements of Comprehensive Income or Loss.
The following table summarizes the changes in other comprehensive (loss) income by component:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| (in thousands) | Pre-tax Amount | | Tax Benefit (Expense) | | Net Amount | | Pre-tax Amount | | Tax (Expense) Benefit | | Net Amount | | Pre-tax Amount | | Tax Benefit (Expense) | | Net Amount |
| Defined benefit plans: | | | | | | | | | | | | | | | | | |
| Other comprehensive income (loss) before reclassifications | $ | 2,107 | | | $ | (360) | | | $ | 1,747 | | | $ | (1,650) | | | $ | 238 | | | $ | (1,412) | | | $ | (3,106) | | | $ | 515 | | | $ | (2,591) | |
| Amounts reclassified to earnings included in "Selling, general and administrative" | (58) | | | 9 | | | (49) | | | 710 | | | (92) | | | 618 | | | 2,021 | | | (329) | | | 1,692 | |
| Foreign currency hedge: | | | | | | | | | | | | | | | | | |
| Other comprehensive income (loss) before reclassifications | 310 | | | (43) | | | 267 | | | (193) | | | 51 | | | (142) | | | 43 | | | (79) | | | (36) | |
| Amounts reclassified to earnings included in "Selling, general and administrative" | 165 | | | (43) | | | 122 | | | 24 | | | (6) | | | 18 | | | (591) | | | 150 | | | (441) | |
| Interest rate hedge: | | | | | | | | | | | | | | | | | |
| Other comprehensive income before reclassifications | 635 | | | — | | | 635 | | | 7,481 | | | (1,820) | | | 5,661 | | | 17,868 | | | (4,013) | | | 13,855 | |
| Amounts reclassified to earnings included in "Interest expense" | (641) | | | 147 | | | (494) | | | (9,276) | | | 1,799 | | | (7,477) | | | (10,189) | | | 2,191 | | | (7,998) | |
| Reclass of realized gain on interest rate swaps termination and prior hedge effectiveness | (1,569) | | | 361 | | | (1,208) | | | (3,579) | | | — | | | (3,579) | | | — | | | — | | | — | |
| Available-for-sale securities: | | | | | | | | | | | | | | | | | |
| Other comprehensive loss before reclassifications | (3,195) | | | 1,564 | | | (1,631) | | | — | | | — | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | |
| Cumulative translation adjustment | 5,014 | | | — | | | 5,014 | | | (2,773) | | | — | | | (2,773) | | | (10,834) | | | — | | | (10,834) | |
| Other comprehensive income (loss) | $ | 2,768 | | | $ | 1,635 | | | $ | 4,403 | | | $ | (9,256) | | | $ | 170 | | | $ | (9,086) | | | $ | (4,788) | | | $ | (1,565) | | | $ | (6,353) | |
| | | | | | | | | | | | | | | | | |
Accumulated Other Comprehensive Income or Loss
The following table summarizes the changes in accumulated other comprehensive income (loss) by component:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in thousands) | Defined Benefit Plans | | Foreign Currency Hedge | | Interest Rate Hedge | | Available-for-Sale Securities | | Cumulative Translation Adjustment | | Accumulated Other Comprehensive Income (Loss) |
| Balance as of January 29, 2023 | $ | (221) | | | $ | 558 | | | $ | (286) | | | $ | 2,527 | | | $ | 782 | | | $ | 3,360 | |
| Other comprehensive (loss) income | (899) | | | (477) | | | 5,857 | | | — | | | (10,834) | | | (6,353) | |
| Balance as of January 28, 2024 | (1,120) | | | 81 | | | 5,571 | | | 2,527 | | | (10,052) | | | (2,993) | |
| Other comprehensive loss | (794) | | | (124) | | | (5,395) | | | — | | | (2,773) | | | (9,086) | |
| Balance as of January 26, 2025 | (1,914) | | | (43) | | | 176 | | | 2,527 | | | (12,825) | | | (12,079) | |
| Other comprehensive income (loss) | 1,698 | | | 389 | | | (1,067) | | | (1,631) | | | 5,014 | | | 4,403 | |
| Balance as of January 25, 2026 | $ | (216) | | | $ | 346 | | | $ | (891) | | | $ | 896 | | | $ | (7,811) | | | $ | (7,676) | |
Share-Based Compensation
The Company has various equity award plans ("Plans") that provide for granting share-based awards to employees and non-employee directors of the Company. The Plans provide for the granting of several available forms of stock compensation such as non-qualified stock option awards ("NQSOs"), restricted stock unit awards ("RSUs") and equity awards with certain market and/or financial metric-based performance conditions.
The Company measures compensation cost for all share-based payments at fair value on the measurement date, which is typically the grant date. RSUs are valued based on the closing price for a share of Company common stock on the measurement date, while NQSOs are valued using the Black-Scholes pricing model, which considers, among other things, estimates and assumptions on the expected life of options, stock price volatility and the closing price for a share of Company common stock on the measurement date. For performance-based awards with a market condition, the Company uses a Monte Carlo simulation model to estimate grant date fair value, which takes into consideration the range of possible stock price or total stockholder return outcomes. For performance-based awards with a financial metric-based performance condition, the Company values the awards as of the measurement date and compensation cost is recognized using the accelerated attribution method over the requisite service period based on the number of shares that are probable of attainment for each performance period. For financial metric-based restricted stock units with a market condition, the Company uses a combination of a Monte Carlo simulation model and the closing price for a share of Company common stock on the grant date to estimate grant date fair value. In accordance with ASC 718, "Compensation—Stock Compensation," the Company recognizes forfeitures as they occur.
Loss per Share
The computation of basic and diluted loss per share was as follows:
| | | | | | | | | | | | | | | | | | | | |
| | | Fiscal Year Ended |
| (in thousands, except per share data) | | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Net loss attributable to common stockholders | | $ | (40,376) | | | $ | (161,896) | | | $ | (1,092,030) | |
| | | | | | |
| Weighted-average shares outstanding–basic | | 88,374 | | 71,606 | | 64,127 |
| | | | | | |
| | | | | | |
| | | | | | |
| Weighted-average shares outstanding–diluted | | 88,374 | | 71,606 | | 64,127 |
| | | | | | |
| Loss per share: | | | | | | |
| Basic | | $ | (0.46) | | | $ | (2.26) | | | $ | (17.03) | |
| Diluted | | $ | (0.46) | | | $ | (2.26) | | | $ | (17.03) | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Basic earnings or loss per share is computed by dividing income or loss available to common stockholders by the weighted-average number of shares of common stock outstanding during the reporting period. Diluted earnings or loss per share incorporates the incremental shares issuable, calculated using the treasury stock method, upon the assumed exercise of NQSOs and the vesting of RSUs, market-condition RSUs, financial metric-based RSUs and financial metric-based RSUs with a market condition if certain conditions have been met, but excludes such incremental shares that would have an anti-dilutive effect. Due to the Company's net loss for fiscal years 2026, 2025 and 2024, all shares underlying stock options and RSUs were considered anti-dilutive and 3.2 million, 0.2 million and 2.1 million shares underlying stock options and RSUs were excluded from the computation of diluted earnings per share for those periods, respectively.
Any dilutive effect of the 2027 Notes, 2028 Notes and 2030 Notes (as defined in Note 9, Long-Term Debt) is calculated using the if-converted method. For fiscal years 2026, 2025 and 2024, the 2027 Notes were excluded from diluted shares outstanding
due to net loss in such reporting periods, and for fiscal year 2024, they were also excluded because the conversion price exceeded the average market price of the Company's common stock for the reporting period. For fiscal years 2025 and 2024, the 2028 Notes were excluded from diluted shares outstanding due to net loss in such reporting periods. For fiscal year 2026, the 2030 Notes were excluded from diluted shares outstanding because the conversion price exceeded the average market price of the Company's common stock for the reporting periods and due to net loss in the reporting period.
Any dilutive effect of the Warrants (see Note 9, Long-Term Debt) is calculated using the treasury-stock method. For fiscal years 2026, 2025 and 2024, the Warrants were excluded from diluted shares outstanding due to net loss in such reporting periods, and for fiscal years 2025 and 2024 they were also excluded from diluted shares outstanding because the exercise price exceeded the average market price of the Company's common stock for the reporting periods. 2.7 million, 8.6 million and 8.6 million warrants were excluded from the computation of diluted earnings per share for fiscal years 2026, 2025 and 2024, respectively.
Contingencies
From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. The Company is also subject to income tax, indirect tax or other tax claims by tax agencies in jurisdictions in which it conducts business. In addition, the Company is a party to environmental matters including local, regional, state, and federal government clean-up activities at or near locations where the Company currently or has in the past conducted business. The Company is required to assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of reasonably possible losses. A determination of the amount of reserves required for these commitments and contingencies that would be charged to earnings, if any, includes assessing the probability of adverse outcomes and estimating the amount of potential losses. The required reserves, if any, may change due to new developments in each matter or changes in circumstances such as a change in settlement strategy.
From time to time, the Company may record contingent earn-out liabilities, which represent the Company’s requirement to make additional payments related to acquisitions based on certain performance targets achieved during the earn-out periods. The Company measures contingent earn-out liabilities at fair value on a recurring basis using significant unobservable inputs classified within Level 3 of the fair value hierarchy. The significant unobservable inputs used in the fair value measurements are revenue projections over the earn-out period (or other specified performance targets) and the probability outcome percentages assigned to each scenario. Significant increases or decreases to either of these inputs in isolation would result in a significantly higher or lower liability, with a higher liability capped by the contractual maximum of the contingent earn-out obligation.
Recently Adopted Accounting Standards
In November 2024, the FASB issued Accounting Standards Update ("ASU") 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The amendments are effective for the Company for fiscal years beginning after December 15, 2025, with early adoption permitted if the entity has also adopted ASU 2020-06. The Company early adopted ASU 2024-04 during fiscal year 2026 on a prospective basis and applied the amendments in this ASU to the exchange of the 2027 Notes and 2028 Notes (as defined in Note 9, Long-Term Debt). Refer to Note 9, Long-Term Debt for further details.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to require public business entities to disclose sufficient information to enable users of financial statements to understand the nature and magnitude of factors contributing to the difference between the effective tax rate and the statutory tax rate. The amendments in this update provide, among other things, that a business entity must disclose (1) a tabular income tax rate reconciliation, using both percentages and amounts, (2) separate disclosure of any individual reconciling items that are equal to or greater than 5% of the amount computed by multiplying the income (loss) from continuing operations before income taxes by the applicable statutory income tax rate, and disaggregation of certain items that are significant and (3) the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions, including separate disclosure of any individual jurisdictions representing greater than 5% of total income taxes paid. The amendments are effective for the Company for fiscal years beginning after December 15, 2024. Early adoption is permitted and entities may apply the amendments prospectively or may elect retrospective application. The Company adopted ASU 2023-09 on a prospective basis for the fiscal year ended January 25, 2026. Prior period disclosures have not been adjusted to reflect the new disclosure requirements. The adoption of this standard did not have a material impact on the Company’s Consolidated Balance Sheet, Consolidated Statement of Income or Consolidated Statement of Cash Flows. See Note 11, Income Taxes for additional information.
Future Accounting Standards
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which removes all references to prescriptive and sequential software development stages, or "project stages", throughout Subtopic 350-40, and instead specifies that an entity is
required to start capitalizing software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. The amendments are effective for the Company for annual reporting periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted. ASU 2025-06 may be applied using the prospective, modified, or retrospective transition methods. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which allows public business entities a practical expedient. Under this practical expedient, an entity is allowed to assume that the current conditions it has applied in determining credit loss allowances for current accounts receivable and current contract assets remain unchanged for the remaining life of those assets. ASU 2025-05 is effective for the Company for fiscal years beginning after December 15, 2025, and interim reporting periods in those years. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. Entities that elect the practical expedient are required to apply the amendments prospectively. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public business entities to expand disclosures about specific expense categories. The amendments in this ASU require a public entity to disclose, in tabular format, in the notes to the financial statements, specific information about certain costs and expenses. Although the ASU does not change the expense captions an entity presents on the face of the income statement, it requires disaggregation of certain expense captions into specified categories. The amendments are effective for the Company for fiscal years beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its disclosures within the consolidated financial statements.
Note 3: Available-for-sale securities
The following table summarizes the values of the Company’s available-for-sale securities:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| January 25, 2026 | | January 26, 2025 |
| (in thousands) | Fair Value | | Amortized Cost | | Gross Unrealized Gain/(Loss) | | Fair Value | | Amortized Cost | | Gross Unrealized Gain/(Loss) |
| Convertible debt investments | $ | — | | | $ | 5,205 | | | $ | (5,205) | | | $ | 12,715 | | | $ | 14,725 | | | $ | (2,010) | |
| Total available-for-sale securities | $ | — | | | $ | 5,205 | | | $ | (5,205) | | | $ | 12,715 | | | $ | 14,725 | | | $ | (2,010) | |
The Company's available-for-sale securities, all of which mature within one year, consist of investments in convertible debt instruments issued by privately-held companies and are recorded at fair value. See Note 4, Fair Value Measurements, for further discussion of the valuation of the available-for-sale securities. The available-for-sale securities with maturities within one year are included in "Other current assets" and with maturities greater than one year are included in "Other assets" in the Balance Sheets. Unrealized gains or losses, net of tax, are recorded in "Accumulated other comprehensive (loss) income, net" in the Balance Sheets, and realized gains or losses as well as current expected credit loss reserves are recorded in "Non-operating income, net" in the Statements of Operations.
In fiscal year 2026, the Company reduced its convertible debt investments by $3.2 million due to a decrease in fair market value of its available-for-sale debt securities and by $9.5 million due to other-than temporary impairments, in each case based on Level 3 inputs.
Note 4: Fair Value Measurements
Instruments Measured at Fair Value on a Recurring Basis
The fair values of financial assets and liabilities measured and recorded at fair value on a recurring basis were presented in the Balance Sheets as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| January 25, 2026 | | January 26, 2025 |
| (in thousands) | Total | | (Level 1) | | (Level 2) | | (Level 3) | | Total | | (Level 1) | | (Level 2) | | (Level 3) |
| Financial assets: | | | | | | | | | | | | | | | |
| Interest rate swap agreement | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 745 | | | $ | — | | | $ | 745 | | | $ | — | |
| | | | | | | | | | | | | | | |
| Convertible debt investments | — | | | — | | | — | | | — | | | 12,715 | | | — | | | — | | | 12,715 | |
| Foreign currency forward contracts | 474 | | | — | | | 474 | | | — | | | — | | | — | | | — | | | — | |
| Total financial assets | $ | 474 | | | $ | — | | | $ | 474 | | | $ | — | | | $ | 13,460 | | | $ | — | | | $ | 745 | | | $ | 12,715 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
During the fiscal year ended January 25, 2026, the Company had no transfers of financial assets or liabilities between Level 1 or Level 2. As of January 25, 2026 and January 26, 2025, the Company had not elected the fair value option for any financial assets and liabilities for which such an election would have been permitted.
The convertible debt investments are valued utilizing a combination of estimates that are based on the estimated discounted cash flows associated with the debt and the fair value of the equity into which the debt may be converted, all of which are Level 3 inputs.
The following table presents a reconciliation of the changes in convertible debt investments in the fiscal year ended January 25, 2026:
| | | | | |
| (in thousands) | |
| Balance at January 26, 2025 | $ | 12,715 | |
| |
| |
| Fair market value adjustment to OCI | (3,195) | |
| Other-than-temporary impairment | (9,520) | |
| |
| |
| |
| Balance at January 25, 2026 | $ | — | |
The interest rate swap agreements were measured at fair value using readily available interest rate curves (Level 2 inputs). The fair value of each agreement was determined by comparing, for each settlement, the contract rate to the forward rate and discounting to the present value. Contracts in a gain position were recorded in "Other current assets" and "Other assets" in the Balance Sheets and the value of contracts in a loss position were recorded in "Accrued liabilities" and "Other long term liabilities" in the Balance Sheets.
The foreign currency forward contracts are measured at fair value using readily available foreign currency forward and interest rate curves (Level 2 inputs). The fair value of each contract was determined by comparing the contract rate to the forward rate and discounting to the present value. Contracts in a gain position are recorded in "Other current assets" in the Balance Sheets and the value of contracts in a loss position are recorded in "Accrued liabilities" in the Balance Sheets.
See Note 18, Derivatives and Hedging Activities, for further discussion of the Company's derivative instruments.
Instruments Not Recorded at Fair Value
Some of the Company’s financial instruments are not measured at fair value, but are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents including money market deposits, net receivables, certain other assets, accounts payable, accrued expenses, accrued personnel costs, and other current liabilities. The Company’s revolving loans and Terms Loans (as defined in Note 9, Long-Term Debt) are recorded at cost, which approximates fair value as the debt instruments bear interest at a floating rate. The 2027 Notes, 2028 Notes and 2030 Notes (as defined in Note 9, Long-Term Debt) are carried at face value less unamortized debt issuance costs, with interest expense reflecting the cash coupon plus the amortization of the capitalized issuance costs. The estimated fair values are determined based on the actual bid prices of the 2027 Notes, 2028 Notes and 2030 Notes as of the last business day of the period.
The following table displays the carrying values and fair values of the 2027 Notes, 2028 Notes and 2030 Notes:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | January 25, 2026 | | January 26, 2025 |
| (in thousands) | | Fair Value Hierarchy | | Carrying Value | | Fair Value | | Carrying Value | | Fair Value |
1.625% convertible senior notes due 2027, net (1) | | Level 2 | | $ | 99,176 | | | $ | 221,095 | | | $ | 312,973 | | | $ | 647,943 | |
4.00% convertible senior notes due 2028, net (2) | | Level 2 | | — | | | — | | | 60,352 | | | 225,771 | |
0% convertible senior notes due 2030, net (3) | | Level 2 | | 392,058 | | | 441,537 | | | — | | | — | |
| Total convertible notes, net of debt issuance costs | | | | $ | 491,234 | | | $ | 662,632 | | | $ | 373,325 | | | $ | 873,714 | |
(1) The 1.625% convertible senior notes due 2027, net are reflected net of $1.3 million and $6.5 million of unamortized debt issuance costs as of January 25, 2026 and January 26, 2025, respectively.
(2) The 4.00% convertible senior notes due 2028, net are reflected net of $1.6 million of unamortized debt issuance costs as of January 26, 2025.
(3) The 0% convertible senior notes due 2030, net are reflected net of $10.4 million of unamortized debt issuance costs as of January 25, 2026.
Assets and Liabilities Recorded at Fair Value on a Non-Recurring Basis
The remeasurement of goodwill is classified as a non-recurring Level 3 fair value assessment due to the significance of unobservable inputs developed in the determination of the fair value. The Company used a discounted cash flow model and earnings multiples to determine the estimated fair value of the reporting units. Significant inputs to the reporting unit fair value measurements included forecasted cash flows, discount rates, terminal growth rates and earnings multiples, which were determined by management estimates and assumptions. It is possible that future changes in such circumstances, or in the variables associated with the judgments, assumptions and estimates used in assessing the fair value of the assets, would require the Company to record additional non-cash impairment charges.
The measurement of long-lived assets is classified as a non-recurring Level 3 fair value assessment due to the significance of unobservable inputs developed in the determination of the fair value. The Company used a cash flow model to determine the estimated fair value of the assets. The Company made estimates and assumptions regarding future cash flows, discount rates, long-term growth rates and market approach using market multiples to determine the assets estimated fair value. It is possible that future changes in such circumstances, or in the variables associated with the judgments, assumptions and estimates used in assessing the fair value of the assets, would require the Company to record additional non-cash impairment charges.
During the fiscal year ended January 25, 2026, the Company recorded a total of $84.8 million of pre-tax non-cash goodwill impairment charges for the IoT Connected Services reporting unit and $1.8 million of pre-tax non-cash intangible assets impairment charges. During the fiscal year ended January 26, 2025, the Company recorded a total of $7.5 million of pre-tax non-cash goodwill impairment charges for the IoT Systems–Modules reporting unit and there was no impairment of intangible assets. During the fiscal year ended January 28, 2024, the Company recorded a total of $755.6 million of pre-tax non-cash goodwill impairment charges and $131.4 million of pre-tax non-cash intangible assets impairment charges for the reporting units related to the Sierra Wireless Acquisition (as defined below). Refer to Note 7, Goodwill and Intangible Assets, for further details.
Investment Impairments and Credit Loss Reserves
The total credit loss reserve for the Company's held-to-maturity debt securities and AFS debt securities was $4.5 million and $4.5 million as of January 25, 2026 and January 26, 2025, respectively. During fiscal year 2026, the Company recorded other-than-temporary impairments of $10.4 million on one of our non-marketable equity investments and AFS debt securities. During fiscal year 2025, the Company recorded other-than-temporary impairments of $1.1 million on one of our non-marketable equity investments. During fiscal year 2024, the Company recorded other-than-temporary impairments of $2.6 million on certain non-marketable equity investments and AFS debt securities. Credit loss reserves related to the Company’s available-for-sale debt securities and held-to-maturity debt securities with maturities within one year were included in "Other current assets" and with maturities greater than one year were included in "Other assets" in the Balance Sheets.
Note 5: Inventories
Inventories, consisting of material, material overhead, labor, and manufacturing overhead, are stated at the lower of cost (first-in, first-out) or net realizable value and consisted of the following:
| | | | | | | | | | | |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Raw materials and electronic components | $ | 31,924 | | | $ | 46,333 | |
| Work in progress | 119,319 | | | 87,896 | |
| Finished goods | 44,494 | | | 29,364 | |
| Total inventories | $ | 195,737 | | | $ | 163,593 | |
In fiscal year 2024, the Company recorded $3.3 million of amortization of inventory step-up related to the Sierra Wireless Acquisition in "Cost of sales" in the Statements of Operations. No amortization of inventory step-up was recorded in fiscal years 2026 and 2025.
Note 6: Property, Plant and Equipment
The following is a summary of property, plant and equipment:
| | | | | | | | | | | | | | | | | |
| (in thousands) | Estimated Useful Lives | | January 25, 2026 | | January 26, 2025 |
| Land | | | $ | 13,577 | | | $ | 13,577 | |
| Buildings | 7 to 39 years | | 49,890 | | | 49,900 | |
| Leasehold improvements | 2 to 10 years | | 13,576 | | | 13,438 | |
| Machinery and equipment | 3 to 8 years | | 275,347 | | | 269,874 | |
| Computer hardware and software | 3 to 13 years | | 85,012 | | | 80,666 | |
| Furniture and office equipment | 5 to 7 years | | 7,931 | | | 7,780 | |
| Construction in progress | | | 4,343 | | | 4,933 | |
| Property, plant and equipment, gross | | | 449,676 | | | 440,168 | |
| Less: accumulated depreciation and amortization | | | (340,331) | | | (313,978) | |
| Property, plant and equipment, net | | | $ | 109,345 | | | $ | 126,190 | |
As of January 25, 2026 and January 26, 2025, construction in progress consisted primarily of machinery and equipment awaiting completion of installation and being placed in service.
Depreciation expense was $29.9 million, $33.2 million, and $29.3 million in fiscal years 2026, 2025 and 2024, respectively.
Note 7: Goodwill and Intangible Assets
Goodwill
The following table summarizes goodwill by applicable operating segments:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance as of January 25, 2026 | | Balance as of January 26, 2025 |
| (in thousands) | Goodwill | | Accumulated Impairment Losses | | Carrying Value | | Goodwill | | Accumulated Impairment Losses | | Carrying Value |
| Signal Integrity | $ | 267,205 | | | $ | — | | | $ | 267,205 | | | $ | 267,205 | | | $ | — | | | $ | 267,205 | |
Analog Mixed Signal and Wireless | 91,068 | | | — | | | 91,068 | | | 83,101 | | | — | | | 83,101 | |
| IoT Systems and Connectivity | 947,548 | | | (847,896) | | | 99,652 | | | 945,896 | | | (763,111) | | | 182,785 | |
| Total goodwill | $ | 1,305,821 | | | $ | (847,896) | | | $ | 457,925 | | | $ | 1,296,202 | | | $ | (763,111) | | | $ | 533,091 | |
The following table summarizes the change in goodwill by applicable operating segments:
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in thousands) | Signal Integrity | | Analog Mixed Signal and Wireless | | IoT Systems and Connectivity | | | | | | Total |
| Balance at January 26, 2025 | $ | 267,205 | | | $ | 83,101 | | | $ | 182,785 | | | | | | | $ | 533,091 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Addition from acquisition | — | | | 7,967 | | | — | | | | | | | 7,967 | |
| | | | | | | | | | | |
| Cumulative translation adjustment | — | | | — | | | 1,652 | | | | | | | 1,652 | |
| Impairment | — | | | — | | | (84,785) | | | | | | | (84,785) | |
| Balance at January 25, 2026 | $ | 267,205 | | | $ | 91,068 | | | $ | 99,652 | | | | | | | $ | 457,925 | |
During the fourth quarter of fiscal year 2026, the Company completed an immaterial acquisition, which resulted in the addition of $8.0 million in the carrying value of goodwill.
The Company currently has three operating segments—Signal Integrity ("SIP"), Analog Mixed Signal and Wireless ("AMW"), and IoT Systems and Connectivity ("ISC"). As of January 25, 2026 the Company has six reporting units—Signal Integrity, Advanced Protection and Sensing, Wireless, IoT Systems–Modules, IoT Systems–Routers and IoT Connected Services. SIP operating segment includes the Signal Integrity reporting unit, AMW operating segment includes the Advanced Protection and Sensing and Wireless reporting units, and ISC operating segment includes the IoT Systems–Modules, IoT Systems–Routers and IoT Connected Services reporting units. See Note 15, Segment Information, for further discussion of the Company's operating and reportable segments.
Goodwill is not amortized, but is tested for impairment at the reporting unit level using either a qualitative or quantitative assessment on an annual basis during the fourth quarter of each fiscal year, and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Impairment of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair market value of the reporting unit.
A total of $84.8 million of pre-tax non-cash goodwill impairment charges were recorded for fiscal year 2026 in the Statements of Operations. During the second quarter of fiscal year 2026, as a result of reduced earnings forecasts of the IoT Connected Services reporting unit, the Company performed an interim impairment test using a quantitative assessment of IoT Connected Services, included in the IoT Systems and Connectivity operating segment. The interim impairment test resulted in $42.0 million of total pre-tax non-cash goodwill impairment charges for IoT Connected Services recorded in the Statements of Operations during the second quarter of fiscal year 2026. During the fourth quarter of fiscal year 2026, the Company performed its annual goodwill and intangible asset impairment assessment using a qualitative assessment for all of its reporting units, with the exception of IoT Connected Services, for which the Company performed a quantitative assessment. Due to a shift in strategic direction associated with this reporting unit, the Company recorded an additional $42.8 million of total pre-tax non-cash goodwill impairment charges for IoT Connected Services and $1.8 million of intangible impairment. There was no goodwill impairment for any of the Company's other reporting units.
The fair value of the reporting unit was determined based on a discounted cash flow model (an income approach) and earnings multiples (a market approach). Significant inputs to the reporting unit fair value measurements included forecasted cash flows, discount rates, terminal growth rates and earnings multiples, which were determined by management estimates and assumptions. The reporting unit fair value measurement is classified as Level 3 in the fair value hierarchy because it involves significant unobservable inputs.
During the fourth quarter of fiscal year 2025, the Company performed its annual goodwill and intangible asset impairment assessment using a qualitative assessment for all of its reporting units, with the exception of IoT Systems–Modules, for which the Company performed a quantitative assessment. Due to a reduction in earnings forecasts associated with this reporting unit,
the Company impaired the remaining IoT Systems–Modules goodwill balance of $7.5 million. There was no goodwill impairment for any of the Company's other reporting units.
A total of $755.6 million of pre-tax non-cash goodwill impairment charges were recorded for fiscal year 2024 in the Statements of Operations as a result of impairment tests performed. The impairment tests were triggered due to a reduction in earnings forecasts associated with the business acquired from Sierra Wireless, adverse macroeconomic conditions including an elevated interest rate environment, and finalization of the measurement period adjustments. The Company recorded $209.0 million of goodwill impairment for the IoT Connected Services reporting unit, $245.2 million of goodwill impairment for the IoT Systems–Modules reporting unit and $301.4 million of goodwill impairment for the IoT Systems–Routers reporting unit, resulting from quantitative assessments of the reporting units. There was no goodwill impairment for any of the Company's other reporting units. The fair values of these reporting units were determined based on a discounted cash flow model (an income approach) and earnings multiples (a market approach). Significant inputs to the reporting unit fair value measurements included forecasted cash flows, discount rates, terminal growth rates and earnings multiples, which were determined by management estimates and assumptions. The reporting unit fair value measurements are classified as Level 3 in the fair value hierarchy because they involve significant unobservable inputs.
In performing the annual goodwill impairment testing during the fourth quarter of fiscal year 2024, the Company also determined that the carrying amounts of our asset groups related to the Sierra Wireless Acquisition may not be recoverable. The Company therefore performed impairment tests on the long-lived assets in each asset group, including definite-lived intangible assets using an undiscounted cash flow analysis, to determine whether the carrying amounts of each asset group related to the Sierra Wireless Acquisition are recoverable. All three asset groups failed the undiscounted cash flow recoverability test and therefore the Company estimated the fair value of the asset group to determine whether any asset impairment was present. The Company’s estimation of the fair value of the long-lived assets included the use of discounted cash flow analyses. Based on these analyses, the Company concluded that the fair values of certain assets were lower than their carrying amounts. During the fourth quarter of fiscal year 2024, the Company recognized intangible impairment charges of $91.8 million for core technologies, $34.8 million for customer relationships and $4.8 million for trade name, reducing the carrying amounts to $28.1 million for core technologies, $4.1 million for customer relationships and $1.5 million for trade name.
Purchased and Other Intangibles
The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions, which are amortized over their estimated useful lives:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | January 25, 2026 |
| (in thousands) | Estimated Useful Life | | Gross Carrying Amount | | Accumulated Amortization | | Accumulated Impairment | | Net Carrying Amount |
| Core technologies | 1-8 years | | $ | 167,178 | | | $ | (54,383) | | | (91,792) | | | $ | 21,003 | |
| Customer relationships | 1-10 years | | 53,248 | | | (15,265) | | | (34,777) | | | 3,206 | |
| Trade name | 2-10 years | | 9,000 | | | (3,257) | | | (4,816) | | | 927 | |
| Capitalized development costs | 3-7 years | | 3,912 | | | (1,023) | | | (1,777) | | | 1,112 | |
| Software licenses | 7-10 years | | 3,740 | | | (312) | | | — | | | 3,428 | |
| Total finite-lived intangible assets | | | $ | 237,078 | | | $ | (74,240) | | | $ | (133,162) | | | $ | 29,676 | |
| | | | | | | | | |
| | | January 26, 2025 |
| (in thousands) | Estimated Useful Life | | Gross Carrying Amount | | Accumulated Amortization | | Accumulated Impairment | | Net Carrying Amount |
| Core technologies | 1-8 years | | $ | 154,728 | | | $ | (44,014) | | | (91,792) | | | $ | 18,922 | |
| Customer relationships | 1-10 years | | 51,781 | | | (13,394) | | | (34,777) | | | 3,610 | |
| Trade name | 2-10 years | | 9,000 | | | (3,125) | | | (4,816) | | | 1,059 | |
| Capitalized development costs | 3 years | | 1,368 | | | (278) | | | — | | | 1,090 | |
| Software licenses | 7 years | | 200 | | | (14) | | | — | | | 186 | |
| Total finite-lived intangible assets | | | $ | 217,077 | | | $ | (60,825) | | | $ | (131,385) | | | $ | 24,867 | |
Amortization expense of finite-lived intangible assets was as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Core technologies | $ | 9,193 | | | $ | 9,106 | | | $ | 33,716 | |
| Customer relationships | 499 | | | 459 | | | 12,345 | |
| Trade name | 132 | | | 425 | | | 2,568 | |
| Capitalized development costs | 745 | | | 278 | | | — | |
| Software licenses | 298 | | | 14 | | | — | |
| Total amortization expense | $ | 10,867 | | | $ | 10,282 | | | $ | 48,629 | |
Amortization expense of finite-lived intangible assets related to core technologies was recorded in "Amortization of acquired technology" within "Total cost of sales" in the Statements of Operations and amortization expense of finite-lived intangible assets related to customer relationships and trade name was recorded in "Intangible amortization" within "Total operating expenses, net" in the Statements of Operations. Amortization expense of finite-lived intangible assets related to software licenses was recorded in "Cost of sales" in the Statements of Operations and amortization expense of finite-lived intangible assets related to capitalized development costs was recorded in "Product development and engineering" in the Statements of Operations.
Future amortization expense of finite-lived intangible assets is expected as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in thousands) | Core Technologies | | Customer Relationships | | Trade Name | | Capitalized Development Costs | | Software Licenses | | Total |
| Fiscal year 2027 | $ | 6,035 | | | $ | 631 | | | $ | 133 | | | $ | 565 | | | $ | 384 | | | $ | 7,748 | |
| Fiscal year 2028 | 4,762 | | | 432 | | | 133 | | | 287 | | | 384 | | | 5,998 | |
| Fiscal year 2029 | 4,276 | | | 432 | | | 133 | | | 57 | | | 384 | | | 5,282 | |
| Fiscal year 2030 | 1,572 | | | 432 | | | 133 | | | 57 | | | 384 | | | 2,578 | |
| Fiscal year 2031 | 1,572 | | | 432 | | | 133 | | | 57 | | | 384 | | | 2,578 | |
| Thereafter | 2,786 | | | 847 | | | 262 | | | 89 | | | 1,508 | | | 5,492 | |
| Total expected amortization expense | $ | 21,003 | | | $ | 3,206 | | | $ | 927 | | | $ | 1,112 | | | $ | 3,428 | | | $ | 29,676 | |
Also in "Other intangible assets, net" in the Balance Sheets, are finite-lived intangible assets to be amortized upon placement in service. The following table sets forth the Company’s finite-lived intangible assets not yet placed in service:
| | | | | | | | | | | | | | | | | | | | |
| (in thousands) | | Capitalized Development Costs | | Software Licenses | | Total |
| Balance at January 26, 2025 | | $ | 2,104 | | | $ | 6,140 | | | $ | 8,244 | |
| Additions | | 2,854 | | | 5,325 | | | 8,179 | |
| Placed in service | | (2,544) | | | (3,540) | | | (6,084) | |
| Balance at January 25, 2026 | | $ | 2,414 | | | $ | 7,925 | | | $ | 10,339 | |
Note 8: Details of Other Current Assets and Accrued Liabilities
The following is a summary of other current assets for fiscal years 2026 and 2025:
| | | | | | | | | | | |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Other receivables | $ | 35,627 | | | $ | 25,599 | |
| Inventory advances | 29,905 | | | 34,835 | |
| Prepaid expenses and deposits | 16,308 | | | 14,608 | |
| Short term portion of investments | — | | | 12,716 | |
| Other | 6,390 | | | 6,312 | |
| Total other current assets | $ | 88,230 | | | $ | 94,070 | |
The following is a summary of accrued liabilities for fiscal years 2026 and 2025:
| | | | | | | | | | | |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Compensation | $ | 55,298 | | | $ | 44,911 | |
| Refund liabilities | 47,359 | | | 39,406 | |
| Accrued inventory | 26,086 | | | 22,106 | |
| Deferred revenue | 14,197 | | | 15,870 | |
| Lease liabilities | 6,063 | | | 6,006 | |
| Professional fees | 4,822 | | | 2,948 | |
| Royalties | 4,415 | | | 3,263 | |
| Inventory purchase commitment | 4,804 | | | 9,440 | |
| Deferred compensation | 3,529 | | | 2,930 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| Other | 25,229 | | | 31,321 | |
| Total accrued liabilities | $ | 191,802 | | | $ | 178,201 | |
Note 9: Long-Term Debt
Long-term debt and the current period interest rates were as follows:
| | | | | | | | | | | |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| | | |
| Term loans | $ | — | | | $ | 181,212 | |
1.625% convertible senior notes due 2027 | 100,500 | | | 319,500 | |
4.00% convertible senior notes due 2028 | — | | | 61,950 | |
0% convertible senior notes due 2030 | 402,500 | | | — | |
| Total debt | 503,000 | | | 562,662 | |
| Current portion, net | — | | | (45,594) | |
| Debt issuance costs | (11,766) | | | (11,135) | |
| Total long-term debt, net of debt issuance costs | $ | 491,234 | | | $ | 505,933 | |
Weighted-average effective interest rate (1) | 0.55 | % | | 4.10 | % |
(1) The revolving loans and Term Loans (as defined below) bear interest at variable rates based on Adjusted Term SOFR or a Base Rate (as defined in the Credit Agreement), at the Company’s option, plus an applicable margin that varies based on the Company’s consolidated leverage ratio. In the first quarter of fiscal year 2024, the Company entered into an interest rate swap agreement with a 2.75 year term to hedge the variability of interest payments on $150.0 million of debt outstanding on the Term Loans at a fixed Term SOFR rate of 3.58%, plus a variable margin and spread based on the Company’s consolidated leverage ratio. As of January 25, 2026, the effective interest rate was a weighted-average rate that represented (a) interest on the remaining debt under the 2027 Notes outstanding at a fixed rate of 1.625%, and (b) interest on the 2030 Notes outstanding at a fixed rate of 0%. As of January 26, 2025, the effective interest rate was a weighted-average rate that represented (a) interest on $150.0 million of the debt outstanding on the Terms Loans at a fixed SOFR rate of 3.58% plus a margin and spread of 3.85% (total fixed rate of 7.43%), (b) interest on the remaining debt outstanding on the Term Loans at a floating SOFR rate of 4.36% plus a margin and spread of 3.85% (total floating rate of 8.21%), (c) interest on the 2027 Notes outstanding at a fixed rate of 1.625%, and (d) interest on the 2028 Notes outstanding at a fixed rate of 4.00%
Credit Agreement
On November 7, 2019, we, with certain of our domestic subsidiaries as guarantors, entered into a credit agreement with the lenders party thereto and HSBC Bank USA, National Association ("HSBC Bank"), as administrative agent, swing line lender and letter of credit issuer. On September 26, 2022 (the "Third Restatement Effective Date"), the Company entered into a third amendment and restatement agreement (as amended, restated, supplemented or otherwise modified from time to time, the "Credit Agreement") with the lenders party thereto, HSBC Bank, as resigning administrative agent, and JPMorgan Chase Bank, N.A. ("JPM"), as successor administrative agent, swing line lender and letter of credit issuer. The restated Credit Agreement, which was entered into substantially concurrently with the completion of the acquisition of Sierra Wireless, Inc. on January 12, 2023 (the "Sierra Wireless Acquisition") was entered into to, among other things, (i) extend the maturity date of $405.0 million of the $600.0 million in aggregate principal amount of revolving commitments thereunder from November 7, 2024 to January 12, 2028, (ii) provide for incurrence by the Company on January 12, 2023 of term loans in an aggregate principal amount of $895.0 million, which was used to fund a portion of the cash consideration for the Sierra Wireless Acquisition, (iii) provide for JPM to succeed HSBC Bank as administrative agent and collateral agent under the Credit Agreement on January 12, 2023, (iv) modify the maximum consolidated leverage covenant as set forth in the Credit Agreement, (v) replace LIBOR with adjusted term SOFR and (vi) make certain other changes as set forth in the restated Credit Agreement, including changes consequential to the incorporation of the Term Loan Facility.
After effectiveness of the Fourth Amendment (as defined and described below), the borrowing capacity on the revolving credit facility under the Credit Agreement (the "Revolving Credit Facility") is $455.0 million, which is scheduled to mature on January 12, 2028 (subject to, in certain circumstances, an earlier springing maturity), and the term loans thereunder (the "Term Loans") were scheduled to mature on January 12, 2028 (subject to, in certain circumstances, an earlier springing maturity).
In fiscal year 2025, the Company repaid the outstanding amount of $68.3 million on the Revolving Credit Facility which matured on November 7, 2024 by borrowing against the remaining Revolving Credit Facility scheduled to mature on January 12, 2028. In fiscal year 2025, the Company repaid an additional $215.0 million on the Revolving Credit Facility and repaid $441.4 million on the Term Loans using a combination of the Company's cash on hand and net proceeds from the secondary public offering as discussed in Note 17, Common Stock.
In fiscal year 2026, the Company made early repayments of $181.2 million on the remaining balance of the Term Loans.
As of January 25, 2026, the Company had no amounts outstanding under the Term Loans and no revolving loans outstanding under the Revolving Credit Facility, which had available undrawn borrowing capacity of $451.6 million, subject to net leverage limitations and customary conditions precedent, including the accuracy of representations and warranties and the absence of defaults.
Up to $40.0 million of the Revolving Credit Facility may be used to obtain letters of credit, up to $25.0 million of the Revolving Credit Facility may be used to obtain swing line loans, and up to $75.0 million of the Revolving Credit Facility may be used to obtain revolving loans and letters of credit in certain currencies other than U.S. Dollars ("Alternative Currencies"). The proceeds of the Revolving Credit Facility may be used by the Company for capital expenditures, permitted acquisitions, permitted dividends, working capital and general corporate purposes.
On February 24, 2023, the Company entered into the first amendment (the "First Amendment") to the Credit Agreement, in order to, among other things, (i) increase the maximum consolidated leverage ratio covenant for certain test periods as set forth therein, (ii) reduce the minimum consolidated interest coverage ratio covenant for certain test periods as set forth therein, (iii) provide that, during the period that financial covenant relief pursuant to the First Amendment is in effect, the interest rate margin for (1) Term SOFR loans is deemed to be 2.50% and (2) Base Rate (as defined in the Credit Agreement) loans is deemed to be 1.50% per annum and (iv) make certain other changes as set forth therein.
On June 6, 2023, the Company entered into the second amendment (the "Second Amendment") to the Credit Agreement, in order to, among other things, (i) increase the maximum consolidated leverage ratio covenant for certain test periods as set forth therein and described below, (ii) reduce the minimum consolidated interest coverage ratio covenant for certain test periods as set forth therein and described below, (iii) modify the pricing grid applicable to loans under the Credit Agreement during the covenant relief period as set forth therein and described below, (iv) impose a minimum liquidity covenant for certain periods during the covenant relief period as set forth therein and described below, (v) increase the annual amortization in respect of the term loans thereunder to 7.5% per annum for certain periods as set forth therein, (vi) impose an "anti-cash hoarding" condition to the borrowing of revolving loans as set forth therein, (vii) provide that the maturity date for the Term Loans and revolving loans shall be the day that is 91 days prior to the stated maturity date of the 2027 Notes if such notes have not otherwise been refinanced or extended to at least 91 days after the stated maturity date of the Term Loans and revolving loans, the aggregate principal amount of non-extended outstanding 2027 Notes and certain replacement debt exceeds $50 million and a minimum liquidity condition is not satisfied, (viii) provide for the reduction of the aggregate revolving commitments thereunder by $100 million, (ix) require that the Company appoint a financial advisor and (x) make certain other modifications to the mandatory prepayments (including the imposition of an excess cash flow mandatory prepayment), collateral provisions and covenants (including additional limitations on debt, liens, investments and restricted payments such as dividends) as set forth therein.
Effective June 6, 2023, in connection with the Second Amendment, interest on loans made under the Credit Agreement in U.S. Dollars accrues, at the Company's option, at a rate per annum equal to (1) (x) the Base Rate (as defined in the Credit Agreement) plus (y) a margin ranging from 0.25% to 2.75% depending upon the Company’s consolidated leverage ratio (except that, during the period that financial covenant relief is in effect (including during the extended covenant relief period provided pursuant to the Third Amendment, as defined below), the margin will not be less than 2.25% per annum) or (2) (x) Term SOFR Rate (as defined in the Credit Agreement) plus (y) a credit spread adjustment of (i) for term loans, 0.10% and (ii) for revolving credit borrowings, 0.11%, 0.26% or 0.43% for one, three and six month interest periods, respectively, plus (z) a margin ranging from 1.25% to 3.75% depending upon the Company's consolidated leverage ratio (except that, during the period that financial covenant relief pursuant to the Third Amendment is in effect, the margin will not be less than 3.25% per annum) (such margin, the "Applicable Margin"). Interest on loans made under the Revolving Credit Facility in Alternative Currencies accrues at a rate per annum equal to a customary benchmark rate (including, in certain cases, credit spread adjustments) plus the Applicable Margin.
On October 19, 2023, the Company entered into the third amendment (the "Third Amendment") to the Credit Agreement, in order to, among other things, (i) extend the financial covenant relief period by one year to April 30, 2026, (ii) increase the maximum consolidated leverage ratio covenant for certain test periods as set forth in the Third Amendment, (iii) reduce the minimum consolidated interest coverage ratio covenant for certain test periods as set forth in the Third Amendment and (iv) make certain other changes as set forth therein. These amendments had the effect of extending and temporarily expanding financial covenant relief under the Credit Agreement previously provided for in the First Amendment and Second Amendment.
On April 24, 2025, the Company entered into the fourth amendment (the "Fourth Amendment") to the Credit Agreement, in order to, among other things, increase the total available borrowing capacity under the Revolving Credit Facility by $117.5 million increasing the total facility size to $455.0 million. Other than the foregoing, the material terms of the Credit Agreement remain unchanged.
All of the Company's obligations under the Credit Agreement are unconditionally guaranteed by all of the Company's direct and indirect domestic subsidiaries, other than certain excluded subsidiaries, including, but not limited to, any domestic subsidiary the primary assets of which consist of equity or debt of non-U.S. subsidiaries, certain immaterial non-wholly-owned domestic subsidiaries and subsidiaries that are prohibited from providing a guarantee under applicable law or that would require governmental approval to provide such guarantee. The Company and the guarantors have also pledged substantially all of their assets to secure their obligations under the Credit Agreement.
No amortization is required with respect to the revolving loans. Effective June 6, 2023, in connection with the Second Amendment, the Term Loans amortize (x) during the period that financial covenant relief is in effect (including during the extended covenant relief period provided pursuant to the Third Amendment), in equal quarterly installments of 1.875% of the aggregate principal amount outstanding on the Third Restatement Effective Date, and (y) otherwise, in equal quarterly installments of 1.25% of the aggregate principal amount outstanding on the Third Restatement Effective Date, with the balance due at maturity. The Company may voluntarily prepay borrowings at any time and from time to time, without premium or penalty, other than customary "breakage costs" in certain circumstances. In the third quarter of fiscal year 2024, the Company made a $250.0 million prepayment on the Term Loans in connection with the Third Amendment, after which there is no scheduled amortization remaining on the Term Loans.
The Credit Agreement contains customary representation and warranties, and affirmative and negative covenants, including limitations on the Company’s ability to, among other things, incur indebtedness, create liens on assets, engage in certain fundamental corporate changes, make investments, repurchase stock, pay dividends or make similar distributions, engage in certain affiliate transactions, or enter into agreements that restrict the Company's ability to create liens, pay dividends or make loan repayments. In addition, the Company must comply with financial covenants which, after effectiveness of the Third Amendment are as follows (in each case, during the covenant relief period):
•maintaining a maximum consolidated leverage ratio, determined as of the last day of each fiscal quarter, of (i) 8.17 to 1.00 for the fiscal quarter ending on or around October 31, 2023, (ii) 10.27 to 1.00 for the fiscal quarter ending on or around January 31, 2024, (iii) 10.21 to 1.00 for the fiscal quarter ending on or around April 30, 2024, (iv) 9.93 to 1.00 for the fiscal quarter ending on or around July 31, 2024, (v) 8.42 to 1.00 for the fiscal quarter ending on or around October 31, 2024, (vi) 7.68 to 1.00 for the fiscal quarter ending on or around January 31, 2025, (vii) ) 6.75 to 1.00 for the fiscal quarter ending on or around April 30, 2025, and (viii) 6.28 to 1.00 for the fiscal quarter ending on or around July 31, 2025;
•maintaining a minimum consolidated interest expense coverage ratio, determined as of the last day of each fiscal quarter, of (i) 1.66 to 1.00 for the fiscal quarter ending on or around October 31, 2023, (ii) 1.40 to 1.00 for the fiscal quarter ending on or around January 31, 2024, (iii) 1.37 to 1.00 for the fiscal quarter ending on or around April 30, 2024, (iv) 1.41 to 1.00 for the fiscal quarter ending on or around July 31, 2024, (v) 1.73 to 1.00 for the fiscal quarter ending on or around October 31, 2024, (vi) 1.90 to 1.00 for the fiscal quarter ending on or around January 31, 2025, (vii) 2.14 to 1.00 for the fiscal quarter ending on or around April 30, 2025, and (viii) 2.37 to 1.00 for the fiscal quarter ending on or around July 31, 2025; and
•until January 31, 2025, maintaining a minimum consolidated liquidity (as further defined in the Credit Agreement but excluding revolving credit commitments scheduled to expire in 2024) of $150 million as of the last day of each monthly accounting period of the Company.
In the third quarter of fiscal year 2026, the Company voluntarily terminated the covenant relief period under the Third Amendment. Following such termination, the Company must comply with financial covenants which are as follows:
•maintaining a maximum consolidated leverage ratio, determined as of the last day of each fiscal quarter, of 3.75 to 1.00 for the fiscal quarter ending on or around October 31, 2025 and each fiscal quarter thereafter, subject to increase to 4.25 to 1.00 for the four full consecutive fiscal quarters ending on or after the date of consummation of a permitted acquisition that constitutes a "Material Acquisition" under the Credit Agreement, subject to the satisfaction of certain conditions; and
•maintaining a minimum consolidated interest expense coverage ratio, determined as of the last day of each fiscal quarter, of 3.50 to 1.00 for the fiscal quarter ending on or around October 31, 2025 and each fiscal quarter thereafter.
Compliance with the leverage and interest expense coverage financial covenants is measured quarterly based upon the Company’s performance over the most recent four quarters, and compliance with the liquidity covenant is measured as of the last day of each monthly accounting period. As of January 25, 2026, the Company was in compliance with the financial covenants in the Credit Agreement.
The Credit Agreement also contains customary provisions pertaining to events of default. If any event of default occurs, the obligations under the Credit Agreement may be declared due and payable, terminated upon written notice to the Company and existing letters of credit may be required to be cash collateralized.
The $100.0 million reduction in borrowing capacity of the Revolving Credit Facility in connection with the Second Amendment and the $250.0 million payment on the Term Loans in connection with the Third Amendment resulted in write-offs of deferred financing costs of $4.4 million for fiscal year 2024, which were included in "Interest expense" in the Statements of Operations.
In the first quarter of fiscal year 2024, the Company entered into an interest rate swap agreement with a 2.75 year term to hedge the variability of interest payments on $150.0 million of debt outstanding on the Term Loans at a Term SOFR rate of 3.58%,
plus a variable margin and spread based on the Company’s consolidated leverage ratio. This interest rate swap agreement was partially terminated in the second quarter and fully terminated in the third quarter of fiscal year 2026.
In the fourth quarter of fiscal year 2023, the Company entered into an interest rate swap agreement with a 5 year term to hedge the variability of interest payments on $450.0 million of debt outstanding on the Term Loans at a Term SOFR rate of 3.44%, plus a variable margin and spread based on the Company’s consolidated leverage ratio. This interest rate swap agreement was terminated in the fourth quarter of fiscal year 2025 due to partial repayment of the Term Loans. As a result of the interest rate swap termination, the Company recognized the reclassification of amounts in other comprehensive income to earnings. The recognized amount was a gain of $3.6 million. The Company also received proceeds of $4.8 million upon the interest rate swap termination.
Convertible Senior Notes Due 2027
On October 12, 2022 and October 21, 2022, the Company issued and sold $300.0 million and $19.5 million, respectively, in aggregate principal amount of 1.625% Convertible Senior Notes due 2027 (the "2027 Notes") in a private placement. The 2027 Notes were issued pursuant to an indenture, dated October 12, 2022, by and among the Company, the subsidiary guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee (the "2027 Indenture"). The 2027 Notes are jointly and severally and fully and unconditionally guaranteed by each of the Company’s current and future direct and indirect wholly-owned domestic subsidiaries that guarantee its borrowings under its Credit Agreement. The 2027 Notes bear interest at a rate of 1.625% per year, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2023. The 2027 Notes will mature on November 1, 2027, unless earlier converted, redeemed or repurchased. As of January 25, 2026, $100.5 million of the 2027 Notes remained outstanding.
The initial conversion rate of the 2027 Notes is 26.8325 shares of the Company's common stock per $1,000 principal amount of 2027 Notes (which is equivalent to an initial conversion price of approximately $37.27 per share). The conversion rate is subject to adjustment upon the occurrence of certain events specified in the 2027 Indenture but will not be adjusted for accrued and unpaid interest. In addition, upon the occurrence of a Make-Whole Fundamental Change (as defined in the 2027 Indenture) or if the Company delivers a Notice of Sale Price Redemption (as defined in the 2027 Indenture), the Company will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock as described in the 2027 Indenture for a holder who elects to convert its 2027 Notes in connection with such Make-Whole Fundamental Change or to convert its 2027 Notes called (or deemed called as provided in the 2027 Indenture) for redemption in connection with such Notice of Sale Price Redemption, as the case may be.
Prior to the close of business on the business day immediately preceding July 1, 2027, the 2027 Notes are convertible at the option of the holders thereof only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ended on January 29, 2023 (and only during such fiscal quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day (the "Market Price Condition"); (2) during the five business day period after any ten consecutive trading day period in which, for each trading day of that period, the Trading Price (as defined in the 2027 Indenture), as determined following a request by a holder of the 2027 Notes in accordance with the procedures described in the 2027 Indenture, per $1,000 principal amount of the 2027 Notes for such trading day was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day; (3) if the Company calls such 2027 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the 2027 Notes called (or deemed called as provided in the 2027 Indenture) for redemption; or (4) upon the occurrence of specified corporate events described in the 2027 Indenture. As of January 25, 2026, the Market Price Condition was satisfied, allowing holders of the 2027 Notes to convert their 2027 Notes beginning on January 26, 2026 through April 24, 2026 (the last trading day of the fiscal quarter ending April 26, 2026). Should the holders of the 2027 Notes elect to convert some or all of the outstanding 2027 Notes, the Company intends to draw on its Revolving Credit Facility to settle the obligation. On or after July 1, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2027 Notes, holders of the 2027 Notes may convert all or a portion of their 2027 Notes, regardless of the foregoing conditions. Upon conversion, the 2027 Notes will be settled in cash up to the aggregate principal amount of the 2027 Notes to be converted, and in cash, shares of the Company's common stock or any combination thereof, at the Company's option, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the 2027 Notes being converted.
Effective November 5, 2025 and before the 61st scheduled trading day immediately preceding the maturity date, the Company may redeem for cash all or any portion of the 2027 Notes (subject to the limitation described below), at the Company’s option, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the related notice of sale price redemption, at a redemption price equal to 100% of the principal amount of the 2027 Notes to be
redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all of the outstanding 2027 Notes, at least $75.0 million aggregate principal amount of the 2027 Notes must be outstanding and not subject to redemption as of the relevant redemption notice date. No sinking fund is provided for the 2027 Notes.
Upon the occurrence of a Fundamental Change (as defined in the 2027 Indenture) prior to the maturity date of the 2027 Notes, holders of the 2027 Notes may require the Company to repurchase all or a portion of the 2027 Notes for cash at a price equal to 100% of the principal amount of the 2027 Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the Fundamental Change Repurchase Date (as defined in the 2027 Indenture).
Convertible Note Hedge Transactions
On October 6, 2022 and October 19, 2022, the Company entered into privately negotiated convertible note hedge transactions (the "Convertible Note Hedges") with an affiliate of one of the initial purchasers of the 2027 Notes and another financial institution (collectively, the "Counterparties") whereby the Company has the option to purchase the same number of shares of the Company’s common stock initially underlying the 2027 Notes in the aggregate for approximately $37.27 per share, which is subject to anti-dilution adjustments substantially similar to those in the 2027 Notes. The Convertible Note Hedges will expire upon the maturity of the 2027 Notes, if not earlier exercised. The Convertible Note Hedges are expected to reduce the potential dilution to the common stock upon the conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted 2027 Notes, as the case may be, in the event that the market price per share of common stock, as measured under the terms of the Convertible Note Hedges, is greater than the strike price of the Convertible Note Hedges, which initially corresponds to the initial conversion price of the 2027 Notes, or approximately $37.27 per share of the common stock. The Convertible Note Hedges are separate transactions, entered into by the Company with each of the Counterparties, and are not part of the terms of the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Convertible Note Hedges. The Company used approximately $72.6 million of the net proceeds from the offering of the 2027 Notes to pay the cost of the Convertible Note Hedges. The Convertible Note Hedges are recorded in "Additional paid-in capital" in the Balance Sheets as they do not require classification outside of equity pursuant to ASC 480 and qualify for equity classification pursuant to ASC 815.
Warrant Transactions
On October 6, 2022 and on October 19, 2022, the Company separately entered into privately negotiated warrant transactions (the "Warrants") with the Counterparties whereby the holders of the Warrants have the option to acquire, collectively, subject to customary adjustments, approximately 8.6 million shares of the Company’s common stock at an initial strike price of approximately $51.15 per share. The Warrants were sold in private placements to the Counterparties pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), afforded by Section 4(a)(2) of the Securities Act. If the market price per share of the common stock, as measured under the terms of the Warrants, exceeds the strike price of the Warrants, the Warrants could have a dilutive effect on the common stock, unless the Company elects, subject to certain conditions, to settle the Warrants in cash. The Warrants will expire over a period beginning in February 2028.
The Warrants are separate transactions, entered into by the Company with each of the Counterparties, and are not part of the terms of the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Warrants. The Company received aggregate proceeds of approximately $42.9 million from the sale of the Warrants to the Counterparties. The Warrants are recorded in "Additional paid-in capital" in the Balance Sheets as they do not require classification outside of equity pursuant to ASC 480 and qualify for equity classification pursuant to ASC 815.
In combination, the Convertible Note Hedges and the Warrants are intended to synthetically increase the strike price of the conversion option of the 2027 Notes from approximately $37.27 to $51.15 (subject to adjustment in accordance with the terms of the agreements governing such transactions), with the expected result of reducing the dilutive effect of the 2027 Notes in exchange for a net cash premium of $29.7 million.
Exchange of 2027 Notes and Related Unwinding of Convertible Note Hedges and Warrants
On October 7, 2025, the Company entered into separate, privately-negotiated exchange agreements with certain holders of the 2027 Notes (the "2025 Exchange of 2027 Notes"). Pursuant to the 2025 Exchange of 2027 Notes, on October 14, 2025, the Company used approximately $220.6 million of the net proceeds from the 2030 Notes (discussed below), together with the issuance of 3,036,192 shares of the Company's common stock as consideration for the exchange of approximately $219.0 million aggregate principal amount of the 2027 Notes and accrued interest. The Company accounted for these exchange transactions as an induced conversion. In fiscal year 2026, in connection with the exchange transactions, the Company recognized an induced conversion expense of $17.6 million recorded in "Interest expense" on the Statements of Operations and an increase to "Additional paid-in capital" of $14.3 million on the Balance Sheets, which included $3.3 million from the write-off of deferred financing costs.
In connection with the 2025 Exchange of 2027 Notes, the Company also terminated a portion of the Convertible Note Hedges and the Warrants corresponding to the number of 2027 Notes exchanged. The Company received approximately $24.5 million in connection with the termination, which was recorded as an increase to "Additional paid-in capital" on the Balance Sheets.
Convertible Senior Notes Due 2028
On October 26, 2023, the Company issued and sold $250.0 million in aggregate principal amount of 4.00% Convertible Senior Notes due 2028 (the "2028 Notes") in a private placement. The 2028 Notes were issued pursuant to an indenture, dated October 26, 2023, by and among the Company, the subsidiary guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee (the "2028 Indenture"). The 2028 Notes were jointly and severally and fully and unconditionally guaranteed by each of the Company’s current and future direct and indirect wholly-owned domestic subsidiaries that guaranteed its borrowings under its Credit Agreement. The 2028 Notes bore interest at a rate of 4.00% per year, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2024. The 2028 Notes were scheduled to mature on November 1, 2028, unless earlier converted, redeemed or repurchased. As of January 25, 2026, as a result of the exchange transactions discussed below, no amounts remain outstanding under the 2028 Notes.
The initial conversion rate of the 2028 Notes was 49.0810 shares of the Company's common stock per $1,000 principal amount of 2028 Notes (which was equivalent to an initial conversion price of approximately $20.37 per share). The conversion rate was subject to adjustment upon the occurrence of certain events specified in the 2028 Indenture but was not adjusted for accrued and unpaid interest. In addition, upon the occurrence of a Make-Whole Fundamental Change (as defined in the 2028 Indenture) or if the Company delivered a Notice of Redemption (as defined in the 2028 Indenture), the Company would have, in certain circumstances, increased the conversion rate by a number of additional shares of common stock as described in the 2028 Indenture for a holder who elected to convert its 2028 Notes in connection with such Make-Whole Fundamental Change or to convert its 2028 Notes called (or deemed called as provided in the 2028 Indenture) for redemption in connection with such Notice of Redemption.
Prior to the close of business on the business day immediately preceding August 1, 2028, the 2028 Notes would have been convertible at the option of the holders thereof only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ended on January 28, 2024 (and only during such fiscal quarter), if the last reported sale price of the Company's common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter was greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which, for each trading day of that period, the Trading Price (as defined in the 2028 Indenture), as determined following a request by a holder of the 2028 Notes in accordance with the procedures described in the Indenture, per $1,000 principal amount of the 2028 Notes for such trading day was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day; (3) if the Company called such 2028 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the 2028 Notes called (or deemed called as provided in the 2028 Indenture) for redemption; or (4) upon the occurrence of specified corporate events described in the 2028 Indenture.
Exchanges of 2028 Notes
On July 11, 2024 and July 15, 2024, the Company entered into separate, privately negotiated exchange agreements with certain holders of the 2028 Notes (the "2024 Exchange of 2028 Notes"). Pursuant to the 2024 Exchange of 2028 Notes, on July 24, 2024 certain holders exchanged with the Company approximately $188.1 million in aggregate principal amount of the 2028 Notes held by them for an aggregate of 10,378,431 shares of the Company's common stock, which number of shares was determined over an averaging period that commenced on July 12, 2024. The Company accounted for these exchange transactions as a partial debt extinguishment and recognized a loss on extinguishment of debt equal to the difference between the fair value of the Company's common stock delivered to certain holders of the 2028 Notes and the carrying value of the outstanding debt, accrued interest and third-party fees related to the 2024 Exchange of 2028 Notes. In fiscal year 2025, in connection with these exchange transactions, the Company recognized $144.7 million of loss included in "Loss on extinguishment of debt" in the Statements of Operations and $5.5 million of loss resulting from the write-off of deferred financing costs included in "Interest expense" in the Statements of Operations.
On October 7, 2025, the Company entered into separate, privately-negotiated exchange agreements with holders of the 2028 Notes (the "2025 Exchange of 2028 Notes"). Pursuant to the 2025 Exchange of 2028 Notes, on October 14, 2025, the Company used approximately $63.1 million of the net proceeds from the 2030 Notes (discussed below), together with the issuance of 2,217,394 shares of the Company's common stock as consideration for the exchange of the remaining $62.0 million aggregate principal amount of the 2028 Notes and accrued interest. The Company accounted for these exchange transactions as an induced conversion. In fiscal year 2026, in connection with these exchange transactions, the Company recognized an induced conversion expense of $3.6 million recorded in "Interest expense" on the Statements of Operations and an increase to "Additional paid-in capital" of $2.2 million on the Balance Sheets, which included $1.3 million from the write-off of deferred financing costs.
Convertible Senior Notes Due 2030
On October 10, 2025, the Company issued and sold $402.5 million in aggregate principal amount of 0% Convertible Senior Notes due 2030 (the "2030 Notes") in a private placement. The 2030 Notes were issued pursuant to an indenture, dated October 10, 2025, by and among the Company, the subsidiary guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee (the "2030 Indenture"). The 2030 Notes are jointly and severally and fully and unconditionally guaranteed by each of the Company's current and future direct and indirect wholly-owned domestic subsidiaries that guarantee its borrowings under its Credit Agreement. The 2030 Notes do not bear any interest and will mature on October 15, 2030, unless earlier converted, redeemed or repurchased. As of January 25, 2026, $402.5 million of the 2030 Notes remain outstanding.
The initial conversion rate of the 2030 Notes is 9.8964 shares of the Company's common stock per $1,000 principal amount of 2030 Notes (which is equivalent to an initial conversion price of approximately $101.05 per share). The conversion rate is subject to adjustment upon the occurrence of certain events specified in the 2030 Indenture. In addition, upon the occurrence of a Make-Whole Fundamental Change (as defined in the 2030 Indenture) or if the Company delivers a Notice of Redemption (as defined in the 2030 Indenture), the Company will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock as described in the 2030 Indenture for a holder who elects to convert its 2030 Notes in connection with such Make-Whole Fundamental Change or to convert its 2030 Notes called (or deemed called as provided in the 2030 Indenture) for redemption in connection with such Notice of Redemption, as the case may be.
Prior to the close of business on the business day immediately preceding July 15, 2030, the 2030 Notes are convertible at the option of the holders thereof only under the following circumstances: (1) during any fiscal quarter commencing after the fiscal quarter ending on January 25, 2026 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which the trading price per $1,000 principal amount of the 2030 Notes for each trading day of that period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate for the 2030 Notes on each such trading day; (3) if the Company calls such 2030 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date, but only with respect to the 2030 Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events described in the 2030 Indenture. As of January 25, 2026, none of the conditions allowing holders of the 2030 Notes to convert had been met. On or after July 15, 2030, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2030 Notes, regardless of the foregoing circumstances. Upon conversion, the Company will settle conversions by paying cash up to the aggregate principal amount of the 2030 Notes being converted and paying or delivering, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, in respect of the remainder, if any, of the Company’s conversion obligation in excess of the aggregate principal amount of the 2030 Notes being converted.
The 2030 Notes will not be redeemable before October 20, 2028. The 2030 Notes will be redeemable, in whole or in part (subject to certain limitations), for cash at the Company’s option at any time, and from time to time, on or after October 20, 2028, and prior to the 21st scheduled trading day immediately preceding the maturity date, but only if the last reported sale price per share of the Company’s common stock has been at least 130% of the conversion price for the 2030 Notes then in effect on (i) each of at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption and (ii) the trading day immediately preceding the date the Company sends such notice, at a redemption price equal to 100% of the principal amount of the 2030 Notes to be redeemed, plus accrued and unpaid special interest, if any, to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding 2030 Notes, at least $75.0 million aggregate principal amount of 2030 Notes must be outstanding and not subject to redemption as of the relevant redemption date. No sinking fund is provided for the 2030 Notes, which means that the Company is not required to redeem or retire the 2030 Notes periodically.
Capped Call Transactions
On October 7, 2025 and on October 8, 2025, the Company entered into privately negotiated capped call transactions (the "Capped Calls") with various financial institutions (collectively, the "Option Counterparties"). The Capped Calls cover, subject to customary adjustments, the number of shares of common stock that initially underlie the 2030 Notes sold. The Capped Calls have an initial strike price of approximately $101.05 per share, subject to adjustments, which corresponds to the approximate initial conversion price of the 2030 Notes. The Capped Calls are expected generally to reduce potential dilution to the common stock upon any conversion of 2030 Notes and/or offset any cash payments the Company would be required to make in excess of the principal amount of converted 2030 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. If, however, the market price per share of common stock exceeds the cap price of the Capped Calls, there would be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that the then-market
price per share of the common stock exceeds the cap price. The cap price of the Capped Calls is initially approximately $141.82 per share, which represents a premium of 100% over the last reported sale price of the common stock of $70.91 per share on October 7, 2025, and is subject to certain customary adjustments under the terms of the Capped Calls.
The Capped Calls are separate transactions, entered into by the Company with each of the Option Counterparties, and are not part of the terms of the 2030 Notes. Holders of the 2030 Notes do not have any rights with respect to the Capped Calls. The Company paid approximately $31.4 million for the Capped Calls. The Capped Calls are recorded in "Additional paid-in capital" in the Balance Sheets as they do not require classification outside of equity pursuant to ASC 480 and qualify for equity classification pursuant to ASC 815.
Interest Expense
Interest expense was comprised of the following components for the periods presented:
| | | | | | | | | | | | | | | | | |
| | Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Contractual interest | $ | 14,345 | | | $ | 81,353 | | | $ | 94,233 | |
| Interest rate swap agreement | (233) | | | (9,227) | | | (10,186) | |
| Amortization of deferred financing costs | 4,788 | | | 8,274 | | | 7,320 | |
| Write-off of deferred financing costs | 2,388 | | | 13,246 | | | 4,446 | |
| Interest rate swap termination | (1,858) | | | (3,579) | | | — | |
| Induced conversion expense | 21,188 | | | — | | | — | |
| | | | | |
| Total interest expense | $ | 40,618 | | | $ | 90,067 | | | $ | 95,813 | |
As of January 25, 2026 and January 26, 2025, there was $3.4 million and $2.9 million, respectively, outstanding under letters of credit under the Revolving Credit Facility.
Note 10: Share-Based Compensation
Financial Statement Effects and Presentation
Pre-tax share-based compensation was included in the Statements of Operations for fiscal years 2026, 2025 and 2024 as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Cost of sales | $ | 2,697 | | | $ | 2,933 | | | $ | 1,995 | |
| Product development and engineering | 15,098 | | | 13,965 | | | 12,844 | |
| Selling, general and administrative | 39,928 | | | 51,138 | | | 25,331 | |
| Share-based compensation | $ | 57,723 | | | $ | 68,036 | | | $ | 40,170 | |
| | | | | |
Restricted Stock Units, Employees
The Company grants restricted stock units to certain employees of which a portion are expected to be settled with shares of the Company's common stock and a portion are expected to be settled in cash. The restricted stock units that are to be settled with shares are accounted for as equity. The grant date for these awards is equal to the measurement date and they are valued as of the measurement date, based on the closing price for a share of Company common stock on the grant date, and recognized as share-based compensation expense over the requisite vesting period (typically between 1 and 4 years). The restricted stock units that are to be settled in cash are accounted for as liabilities and the value of the awards is re-measured at the end of each reporting period until settlement at the end of the requisite vesting period (typically 3 years).
The following table summarizes the activity for restricted stock units awarded to employees for fiscal year 2026:
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in thousands, except per share data) | Total Units | | Units Subject to Share Settlement | | Units Subject to Cash Settlement | | Weighted-Average Grant Date Fair Value (per share) | | | | |
| Nonvested at January 26, 2025 | 2,720 | | | 2,716 | | | 4 | | | $ | 28.94 | | | | | |
| Granted | 1,136 | | | 1,136 | | | — | | | 44.22 | | | | | |
| Vested | (1,296) | | | (1,294) | | | (2) | | | 30.72 | | | | | |
| Forfeited | (214) | | | (214) | | | — | | | 30.79 | | | | | |
| Nonvested at January 25, 2026 | 2,346 | | | 2,344 | | | 2 | | | 35.21 | | | | | |
The aggregate unrecognized compensation for the non-vested restricted stock units that settle in shares as of January 25, 2026 was $62.5 million, which will be recognized over a weighted-average period of 1.7 years. The aggregate unrecognized compensation for the non-vested restricted stock units that settle in cash as of January 25, 2026 was $0.1 million, which will be recognized over a weighted-average period of 0.1 years.
Restricted Stock Units, Non-Employee Directors
The Company maintains a compensation program pursuant to which restricted stock units are granted to the Company’s directors that are not employed by the Company or any of its subsidiaries. Under the Company's director compensation program in effect prior to the Company's 2025 annual meeting of stockholders, a portion of the stock units granted under the program would be settled in cash and a portion would be settled in shares of the Company's common stock. Stock units granted under the program in connection with and following the Company's 2025 annual meeting of stockholders will be settled in shares of the Company's common stock. Restricted stock units awarded under the program are scheduled to vest on the earlier of (i) one year after the grant date or (ii) the day immediately preceding the first annual meeting of the Company's stockholders following the grant. Restricted stock units awarded under the program that are to be settled in cash will, subject to vesting, be settled when the director who received the award separates from service. Restricted stock units awarded under the program that are to be settled in shares of stock will, subject to vesting, be settled promptly following vesting; provided that a director may elect to defer the settlement date to the director's separation from service pursuant to the Company's Director Deferred Compensation Plan (Non-Employee).
The restricted stock units that are to be settled in cash are accounted for as liabilities. These awards are not typically settled until a non-employee director’s separation from service. The value of both the unvested and vested but unsettled awards are re-measured at the end of each reporting period until settlement. As of January 25, 2026, the total number of unvested and vested but unsettled awards was 133,457 units and the liability associated with these awards was $11.3 million, of which $3.8 million was included in "Accrued liabilities" in the Balance Sheets related to one previous non-employee director currently serving a short-term non-employee consultancy for the Company. The remaining $7.5 million was included in "Other long-term liabilities" in the Balance Sheets.
The restricted stock units that are to be settled in shares are accounted for as equity. The grant date for these awards is equal to the measurement date. These awards are valued as of the measurement date, based on the closing price for a share of Company common stock on the grant date, and recognized as share-based compensation expense over the requisite vesting period (typically one year).
The following table summarizes the activity for restricted stock units awarded to non-employee directors for fiscal year 2026:
| | | | | | | | | | | | | | | | | | | | | | | |
| (in thousands, except per share data) | Total Units | | Units Subject to Share Settlement | | Units Subject to Cash Settlement | | Weighted-Average Grant Date Fair Value (per share) |
| Nonvested at January 26, 2025 | 46 | | | 23 | | | 23 | | | $ | 31.50 | |
| Granted | 43 | | | 43 | | | — | | | 37.58 | |
| Vested | (46) | | | (23) | | | (23) | | | 31.50 | |
| Forfeited | — | | | — | | | — | | | — | |
| Nonvested at January 25, 2026 | 43 | | | 43 | | | — | | | 37.58 | |
Financial Metric-Based Restricted Stock Units with a Market Condition
The Company grants financial metric-based restricted stock units with a market condition (the "Performance Awards") to certain executives of the Company, which are settled in shares and accounted for as equity awards. The Performance Awards have both a financial metric-based performance condition and a pre-defined market condition, which together determine the number of shares that ultimately vest, in addition to the condition of continued service. The number of vested shares for each of the three tranches of the awards, which are the one, two and three-year performance periods, is determined based on the Company's attainment of pre-established revenue and non-GAAP operating income targets for the respective performance period. The vesting for tranches after the initial performance period is also dependent on the actual number of vested shares for the preceding performance period. The market condition is determined based upon the Company's total stockholder return ("TSR") benchmarked against the TSR of an index over the three-year performance period. For fiscal year 2026 grants, the benchmark was against the Russell 3000 Index. The market condition functions as a catch-up provision in determining the vesting of the third tranche of the awards based on the performance over the full three-year performance period. Generally, the award recipients must be employed for the entire one-, two-, or three-year performance period in order to vest in the portion of the award corresponding to that performance period.
The grant-date fair values of the first and second tranches of the Performance Awards are valued using the closing stock price on the grant date and the grant-date fair value of the third tranche of the Performance Awards is valued using a Monte Carlo simulation, which takes into consideration the possible outcomes pertaining to the TSR market condition. The compensation cost of the Performance Awards is recognized using the accelerated attribution method over the requisite service period based on the number of shares that are probable of attainment for each fiscal year.
In fiscal year 2026, the Company granted Performance Awards covering 375,987 shares of Company common stock at the targeted performance levels. The weighted-average grant-date fair values for each of the one, two and three-year performance periods over which the Performance Awards vest were $34.20, $34.20 and $44.05, respectively. Under the terms of these awards, assuming the highest performance level of 200% with no cancellations due to forfeitures, the maximum potential number of shares that can be earned in aggregate for the cumulative fiscal years 2026, 2027 and 2028 performance periods would be 751,974 shares. In the fiscal year ended January 25, 2026, Performance Awards covering 45,619 shares at the targeted performance levels were forfeited due to the terminations of certain recipients.
The following table summarizes the activity for the Performance Awards for fiscal year 2026:
| | | | | | | | | | | |
| (in thousands, except per share data) | Total Units | | Weighted-Average Grant Date Fair Value (per share) |
| Nonvested at January 26, 2025 | 369 | | | $ | 42.23 | |
| Granted | 376 | | | 37.48 | |
| Vested | (139) | | | 36.31 | |
Cancelled/Forfeited (1) | (46) | | | 55.08 | |
| Nonvested at January 25, 2026 | 560 | | | 39.46 | |
(1) Primarily represents forfeitures due to the terminations of certain recipients.
Amounts in the table above include the stated number of Performance Awards granted and outstanding. However, the number of Performance Awards that ultimately vest may be higher or lower than the originally granted amounts depending upon the actual achievement level over the performance period.
The aggregate unrecognized compensation expense for Performance Awards as of January 25, 2026 was $13.6 million, which will be recognized over a weighted-average period of 0.9 years.
TSR Market-Condition Restricted Stock Units
The Company grants TSR market-condition restricted stock units (the "TSR Awards") to certain executives of the Company, which are settled in shares and accounted for as equity awards. The TSR Awards have a pre-defined market condition, which determines the number of shares that ultimately vest, as well as a service condition. The market condition is determined based upon the Company’s TSR benchmarked against the TSR of an index over one, two and three-year periods-year performance periods (one-third of the awards vesting each performance period). For fiscal year 2024 grants, the benchmark was against the Russell 3000 Index. Generally, the TSR Awards recipients must be employed for the entire performance period and be an active employee at the time of vesting of the awards. The TSR Awards are valued as of the grant date using a Monte Carlo simulation which takes into consideration the possible outcomes pertaining to the TSR market condition and expense is recognized on a straight-line basis over the requisite service periods and is adjusted for any actual forfeitures.
There were no TSR Awards granted in fiscal years 2026 and 2025. In fiscal year 2024, the Company granted 202,951 TSR Awards.
The following table summarizes the activity for the TSR Awards for fiscal year 2026:
| | | | | | | | | | | |
| (in thousands, except per share data) | Total Units | | Weighted-Average Grant Date Fair Value (per share) |
| Nonvested at January 26, 2025 | 71 | | | $ | 47.26 | |
| Granted | — | | | — | |
| Vested | (52) | | | 47.82 | |
| Cancelled/Forfeited | — | | | — | |
| Nonvested at January 25, 2026 | 19 | | | 45.72 | |
Amounts in the table above include the stated number of awards granted and outstanding. However, the number of awards that ultimately vest may be higher or lower than the originally granted amounts depending upon the actual TSR achievement level over the performance period.
There was no aggregate unrecognized compensation expense for TSR Awards as of January 25, 2026.
Financial Metric-Based Restricted Stock Units
The Company grants financial metric-based restricted stock units (the "Metric-based Awards") to certain executives of the Company, which are settled in shares and accounted for as equity awards. The Metric-based Awards have a performance condition in addition to a service condition. The number of vested shares for each performance period is determined based on the Company’s attainment of pre-established revenue and non-GAAP operating income targets for the respective performance period. The vesting for tranches after the initial performance period is dependent on revenue and non-GAAP operating income for the preceding performance period. The Metric-based Awards are valued as of the measurement date and compensation cost is recognized using the accelerated attribution method over the requisite service period based on the number of shares that are probable of attainment for each fiscal year.
In fiscal year 2024, the Company granted 189,918 Metric-based Awards that vest over one, two and three-year performance periods (one-third of the awards vesting each performance period). There were no Metric-based Awards granted in fiscal years 2026 and 2025. Generally, the Metric-based Awards recipients must be employed for the entire performance period and be an active employee at the time of vesting of the awards.
The following table summarizes the activity for the Metric-based Awards for fiscal year 2026:
| | | | | | | | | | | |
| (in thousands, except per share data) | Total Units | | Weighted-Average Grant Date Fair Value (per share) |
| Nonvested at January 26, 2025 | 59 | | | $ | 30.86 | |
| Granted | — | | | — | |
| Vested | (40) | | | 32.70 | |
| Cancelled/Forfeited | — | | | — | |
| Nonvested at January 25, 2026 | 19 | | | 27.02 | |
Amounts in the table above include the stated number of Metric-based Awards granted and outstanding. However, the number of Metric-based Awards that ultimately vest may be higher or lower than the originally granted amounts depending upon the actual achievement level over the performance period.
There was no aggregate unrecognized compensation expense for Metric-based Awards as of January 25, 2026.
Non-Qualified Stock Options
From time to time, the Company grants non-qualified stock options to employees and/or non-employee directors. The fair values of these grants are measured on the grant date and recognized as expense over the requisite vesting period (typically 3-4 years). The Company uses the Black-Scholes pricing model to value stock options. The maximum contractual term of stock options is generally 6 to 10 years. There were no stock options granted in fiscal years 2026, 2025 or 2024.
The following table summarizes the activity for stock options for fiscal year 2026:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in thousands, except per share data) | Number of Shares | | Weighted- Average Exercise Price (per share) | | Aggregate Intrinsic Value (1) | | | | Number of Shares Exercisable | | Weighted-Average Contractual Term (years) |
| Vested and expected to vest at January 26, 2025 | 286 | | | $ | 29.59 | | | $ | 12,434 | | | | | 150 | | 3.8 |
| | | | | | | | | | | |
| Exercised | (141) | | | 29.50 | | | 5,423 | | | | | | | |
| Forfeited | (6) | | | 29.30 | | | | | | | | | |
| Vested and expected to vest at January 25, 2026 | 139 | | | 29.70 | | | 7,075 | | | | | 139 | | 2.8 |
| Vested and exercisable at January 25, 2026 | 139 | | | 29.70 | | | 7,075 | | | | | | | 2.8 |
| | | | | | | | | | | |
(1) The aggregate intrinsic value of stock options vested and exercisable as of January 25, 2026 is calculated based on the difference between the exercise price and the $80.52 closing price of the Company's common stock as of January 23, 2026 (the last trading day of the fiscal year ended January 25, 2026).
There was no aggregate unrecognized compensation expense for the outstanding stock options as of January 25, 2026.
The following table summarizes information regarding nonvested stock option awards at January 25, 2026:
| | | | | | | | | | | | | | | | | |
| (in thousands, except per share data) | Number of Shares | | Weighted-Average Exercise Price (per share) | | Weighted-Average Grant Date Fair Value (per share) |
| Nonvested at January 26, 2025 | 136 | | | $ | 29.30 | | | $ | 12.77 | |
| | | | | |
| Vested | (130) | | | 29.30 | | | 12.77 | |
| Forfeited | (6) | | | 29.30 | | | 12.77 | |
| Nonvested at January 25, 2026 | — | | | | | |
The number of authorized shares remaining available for grant under the equity incentive plan was 5,773,258 as of January 25, 2026.
Note 11: Income Taxes
The Company's regional income before income taxes and equity in net gains (losses) of equity method investments was as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Domestic | $ | (45,923) | | | $ | (183,751) | | | $ | (306,039) | |
| Foreign | 24,743 | | | 390 | | | (735,516) | |
| Total | $ | (21,180) | | | $ | (183,361) | | | $ | (1,041,555) | |
The provision for income taxes consisted of the following:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Current income tax (benefit) provision | | | | | |
| Federal | $ | (613) | | | $ | (10,416) | | | $ | 1,758 | |
| State | 485 | | | 1,513 | | | 1 | |
| Foreign | 14,111 | | | 9,949 | | | 8,750 | |
| Subtotal | 13,983 | | | 1,046 | | | 10,509 | |
| Deferred income tax (benefit) provision | | | | | |
| Federal | — | | | — | | | 50,938 | |
| State | — | | | — | | | 51 | |
| Foreign | 5,849 | | | (23,058) | | | (10,979) | |
| Subtotal | 5,849 | | | (23,058) | | | 40,010 | |
| Provision for income taxes | $ | 19,832 | | | $ | (22,012) | | | $ | 50,519 | |
The Company adopted ASU 2023-09 "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" on a prospective basis beginning with the year ended January 25, 2026. The following table presents required disclosure pursuant to ASU 2023-09 and reconciles the U.S. federal statutory tax amount and rate to our actual global effective amount and rate for the year ended January 25, 2026:
| | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended | | | | | | | | |
| (in thousands) | January 25, 2026 | | | | |
| U.S. Federal statutory rate | $ | (4,448) | | | 21.0% | | | | | | | | |
| State and local taxes, net of federal income tax effect | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| New York | (245) | | | 1.2% | | | | | | | | |
| Other | (78) | | | 0.4% | | | | | | | | |
| Foreign tax effects | | | | | | | | | | | |
| Switzerland | | | | | | | | | | | |
| Tax rate differential | (3,582) | | | 16.9% | | | | | | | | |
| Shared-based compensation | (2,652) | | | 12.5% | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Rate change on deferreds | (2,425) | | | 11.4% | | | | | | | | |
| Other adjustments | 274 | | | (1.3)% | | | | | | | | |
| Canada | | | | | | | | | | | |
| Tax rate differential | (2,639) | | | 12.5% | | | | | | | | |
| Impact of audit settlements | 409 | | | (1.9)% | | | | | | | | |
| Research and development credits | (6,335) | | | 29.9% | | | | | | | | |
| Goodwill impairment | 8,968 | | | (42.3)% | | | | | | | | |
| | | | | | | | | | | |
| Valuation allowance | 16,117 | | | (76.1)% | | | | | | | | |
| Other adjustments | 688 | | | (3.2)% | | | | | | | | |
| United Kingdom | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Research and development credits | (495) | | | 2.3% | | | | | | | | |
| Other adjustments | (925) | | | 4.4% | | | | | | | | |
| France | | | | | | | | | | | |
| | | | | | | | | | | |
| Goodwill impairment | 2,121 | | | (10.0)% | | | | | | | | |
| | | | | | | | | | | |
| Impact of audit settlements | 1,280 | | | (6.0)% | | | | | | | | |
| | | | | | | | | | | |
| Other adjustments | 85 | | | (0.4)% | | | | | | | | |
| Australia | | | | | | | | | | | |
| | | | | | | | | | | |
| Goodwill impairment | 2,280 | | | (10.8)% | | | | | | | | |
| Other adjustments | 459 | | | (2.2)% | | | | | | | | |
| Other foreign jurisdictions | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Goodwill impairment | 904 | | | (4.3)% | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Other adjustments | 231 | | | (1.1)% | | | | | | | | |
| Effects of Cross-Border tax laws | | | | | | | | | | | |
| Global intangible low-taxes income (GILTI) | 5,808 | | | (27.4)% | | | | | | | | |
| Foreign derived intangible income (subpart F) | 160 | | | (0.8)% | | | | | | | | |
| Section 78 gross up | 2,540 | | | (12.0)% | | | | | | | | |
| Foreign tax credit | (6,750) | | | 31.9% | | | | | | | | |
| Tax credits | | | | | | | | | | | |
| Research and development credit | 327 | | | (1.5)% | | | | | | | | |
| Valuation allowance | (8,790) | | | 41.5% | | | | | | | | |
| | | | | | | | | | | |
| Nontaxable or nondeductible items | | | | | | | | | | | |
| Debt Extinguishment | 5,430 | | | (25.6)% | | | | | | | | |
| Share-based compensation | (1,864) | | | 8.8% | | | | | | | | |
| Disallowed executive compensation | 3,278 | | | (15.5)% | | | | | | | | |
| Goodwill impairment | 6,517 | | | (30.8)% | | | | | | | | |
| Other Adjustments | | | | | | | | | | | |
| Return to provision adjustments | 3,230 | | | (15.3)% | | | | | | | | |
| | | | | | | | | | | |
| Other adjustments | (46) | | | 0.2% | | | | | | | | |
| Effective tax rate | $ | 19,832 | | | (93.6)% | | | | | | | | |
The following table presents the required disclosures prior to the Company's adoption of ASU 2023-09 and reconciles the U.S. federal statutory income tax rate to the actual global effective income tax rate for the fiscal years ended January 26, 2025 and January 28, 2024:
| | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 26, 2025 | | January 28, 2024 |
| Federal income tax at statutory rate | $ | (38,506) | | | $ | (218,726) | |
| State income taxes, net of federal benefit | 1,173 | | | (9,989) | |
| Foreign taxes differential, including withholding taxes | (1,027) | | | (36,408) | |
| Tax credits generated | (9,436) | | | (6,054) | |
| Changes in valuation allowance | 23,847 | | | 149,209 | |
| Gain on intra-entity asset transfer of intangible assets | 11,430 | | | — | |
| Changes in uncertain tax positions | (9,856) | | | 1,877 | |
| True-up on impairment losses | (26,903) | | | — | |
| Equity compensation | 1,825 | | | 2,929 | |
| Nondeductible loss on debt extinguishment | 30,384 | | | — | |
| Rate change on deferreds | (10,382) | | | (2,667) | |
| GILTI and Subpart F income | 7,227 | | | — | |
| | | |
| Goodwill impairment | 2,019 | | | 193,699 | |
| Nondeductible officers compensation | 1,650 | | | 741 | |
| Other | (5,457) | | | (24,092) | |
| Provision for income taxes | $ | (22,012) | | | $ | 50,519 | |
The Company’s tax expense benefited from its operations in lower tax jurisdictions, such as Switzerland, research and foreign tax credits, equity compensation windfall and the impact of a change in tax rates on deferred tax assets. The Company's tax expense increased due to a change in valuation allowance, nondeductible loss on extinguishment of debt, impairment losses on goodwill, taxes related to disallowed executive compensation and an increase in global intangible low-tax income ("GILTI"), driven by the capitalization of R&D costs as mandated by the Tax Cuts and Job Act (the "Tax Act").
Historically, the Company benefited from a Swiss tax holiday that commenced on January 30, 2017. However, Switzerland implemented the OECD Pillar Two rules effective from January 1, 2024. These rules, guided by OECD administrative updates in December 2023, impose a global minimum tax of 15% on multination enterprises with an annual revenue exceeding €750 million in at least two out of the last four years. As of the fourth quarter of fiscal year 2025, the Company reached this threshold and does not benefit from the tax holiday from fiscal year 2025 onwards. The Company recorded the impact as part of our provision for income taxes in fiscal year 2025.
The Creating Helpful Incentives to Produce Semiconductors and Science Act ("CHIPS Act") provides for various incentives and tax credits, including the Advanced Manufacturing Investment Credit ("AMIC"), which equals 25% of qualified investments in an advanced manufacturing facility that is placed in service after December 31, 2022. At least a portion of our current and future capital expenditures and research and development costs are expected to qualify for this credit, which benefits us by allowing us to net the credit received against our costs. The AMIC credit is accounted for outside of ASC 740 as a reduction to the depreciable basis of the assets used in operations and will not have an impact on our effective tax rate.
The Tax Act imposed a U.S. tax on GILTI income that is earned by certain foreign affiliates owned by a U.S. stockholder. In accordance with guidance issued by the FASB, the Company has made a policy election to treat future taxes related to GILTI as a current period expense in the reporting period in which the tax is incurred.
Prior to the enactment of the Tax Act, with few exceptions, U.S. federal income and foreign withholding taxes had not been provided on the excess of the amount for financial reporting over the tax basis of investments in the Company’s foreign subsidiaries that were essentially permanent in duration. With the enactment of the Tax Act, all historic and current foreign earnings are taxed in the U.S. Depending on the jurisdiction, these foreign earnings are potentially subject to a withholding tax, if repatriated. As of January 25, 2026, the historical undistributed earnings of the Company’s foreign subsidiaries are intended to be permanently reinvested outside of the U.S.
Notwithstanding the U.S. taxation of these amounts, the Company has determined that none of its current foreign earnings will be permanently reinvested. If the Company needed to remit all or a portion of its historical undistributed earnings to the U.S. for
investment in its domestic operations, any such remittance could result in increased tax liabilities and a higher effective tax rate. Determination of the amount of the unrecognized deferred tax liability on these unremitted earnings is not practicable.
The components of the net deferred income tax assets and liabilities at January 25, 2026 and January 26, 2025 were as follows:
| | | | | | | | | | | |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Non-current deferred tax assets: | | | |
| Deferred revenue | $ | 2,645 | | | 2,351 | |
| Inventory reserve | 7,951 | | | $ | 7,501 | |
| Bad debt reserve | 731 | | | 405 | |
| Foreign tax credits | 767 | | | 1,790 | |
| Research credit carryforward | 89,563 | | | 91,214 | |
| NOL carryforward | 134,089 | | | 128,595 | |
| Payroll and related accruals | 10,503 | | | 7,989 | |
| Share-based compensation | 5,685 | | | 4,608 | |
| Foreign pension deferred | 315 | | | 793 | |
| Accrued sales reserves | 3,471 | | | 4,332 | |
| Research and development charges | 22,134 | | | 20,374 | |
| Leasing deferred assets | 6,244 | | | 5,930 | |
| OID interest | 2,052 | | | 9,692 | |
| Other reserves | 1,129 | | | 1,463 | |
| Section 163(J) Limitation | 37,556 | | | 34,072 | |
| Other deferred assets | 4,261 | | | 3,558 | |
| Intangibles | 61,060 | | | 67,397 | |
| Valuation allowance | (336,266) | | | (328,203) | |
| Total non-current deferred tax assets | 53,890 | | | 63,861 | |
| Non-current deferred tax liabilities: | | | |
| Property, plant and equipment | (4,788) | | | (7,135) | |
| Goodwill and other intangibles | (8,242) | | | (7,700) | |
| Leasing deferred liabilities | (5,532) | | | (5,334) | |
| Other non-current deferred tax liabilities | (1,241) | | | (3,318) | |
| Total non-current deferred tax liabilities | (19,803) | | | (23,487) | |
| Net deferred tax assets | $ | 34,087 | | | $ | 40,374 | |
As of January 25, 2026, the Company had U.S. gross federal and state research credits available of approximately $10.9 million and $23.1 million, respectively, which are available to offset taxable income. In connection with the Sierra Wireless Acquisition, the Company acquired approximately $4.1 million of fully reserved U.S. research credit carryforwards. The Company's U.S. credits will expire between fiscal years 2029 through 2046. The Company also had gross Canadian research credits available of approximately $70.0 million. Included in the $70.0 million are $56.2 million of Canadian research credit carryforwards that were acquired in connection with the Sierra Wireless Acquisition. The Company's Canadian credits will expire by fiscal year 2046.
As of January 25, 2026, the Company had U.S. gross state NOL carryforwards of $157.5 million, which, subject to certain limitations, are available to offset future taxable income through fiscal year 2046. These will expire at various dates through 2038 for losses generated prior to tax year 2018.
Additionally, the Company had fully reserved gross NOLs in Canada and France, for $108.9 million and $272.3 million respectively, for companies acquired during the Sierra Wireless Acquisition. The Company also has a gross Swiss NOL of $164.6 million, and a gross UK NOL of $10.0 million.
As of January 25, 2026 and January 26, 2025, the Company had approximately $370.4 million and $368.6 million of net deferred tax assets, respectively, the majority of which are in the U.S., Canada and France. The Company has recorded valuation allowances of $336.3 million and $328.2 million against its deferred tax assets at January 25, 2026 and January 26, 2025, respectively, based on the Company's assessment of its ability to utilize its deferred tax assets. The Company reassessed the valuation allowances and evaluated the recoverability of its deferred tax assets, considering all available evidence such as
earnings history and tax planning strategies. After weighing all positive and negative evidence, the Company maintains a valuation allowance for assets if it is more likely than not that some, or all, of its deferred tax assets will not be realized. Positive evidence considered included reversing taxable temporary differences. Negative evidence considered included the cumulative pre-tax losses recorded during the three-year period ended January 25, 2026, on both an annual and cumulative basis. In jurisdictions where the Company has cumulative losses, the Company has recorded a full valuation allowance on deferred tax assets. As of January 26, 2025, the Company continues to maintain full valuation allowance on DTAs in the U.S. and France, as well as a partial valuation allowance on DTAs in Canada. As a result of the Company’s recent performance, there is a reasonable possibility that a portion of the Company’s valuation allowance is no longer needed in future periods. A release of the valuation allowance will likely result in a material tax benefit recognized in the quarter of the release.
Changes in the valuation allowance for the three years ended January 25, 2026 are summarized in the table below:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Beginning balance | $ | 328,203 | | | $ | 304,355 | | | $ | 156,850 | |
| | | | | |
| Additions | 20,537 | | | 35,071 | | | 147,505 | |
| Releases | (12,474) | | | (11,223) | | | — | |
| Ending balance | $ | 336,266 | | | $ | 328,203 | | | $ | 304,355 | |
The current year activity of $8.1 million primarily consists of valuation allowance on deferred tax assets related to disallowed interest expense carried forward in the U.S. and Canada, as well as NOL and R&D credit deferred tax assets in those regions. The change in the valuation allowance of $8.1 million is included in the fiscal year 2026 provision for income taxes in the Consolidated Statements of Operations.
Uncertain Tax Positions
The Company uses a two-step approach to recognize and measure uncertain tax positions ("UTP"). The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits (before federal impact of state items) is as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Beginning balance | $ | 20,966 | | | $ | 36,548 | |
| Net additions based on tax positions related to the current year | 1,868 | | | 1,356 | |
| Additions based on tax positions related to prior years | 438 | | | 646 | |
| Reductions as a result of lapsed statutes | (2,119) | | | (17,584) | |
| Reductions for settlements with tax authorities | (639) | | | — | |
| Ending balance | $ | 20,514 | | | $ | 20,966 | |
Included in the balance of gross unrecognized tax benefits at January 25, 2026 and January 26, 2025, are $4.6 million and $4.8 million, respectively, of net tax benefits (after federal impact of state items) that, if recognized, would impact the effective tax rate. During fiscal year 2026, the Company released a reserve due to the lapse of a statute of limitations. The Company believes that it is reasonably possible that its balance of gross unrecognized tax benefits may decrease by approximately $0.8 million within the next twelve months.
The liability for UTP is reflected on the Balance Sheets as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Deferred tax assets - non-current | $ | 13,943 | | | $ | 14,255 | |
| | | |
| Other long-term liabilities | 4,625 | | | 4,775 | |
| Total uncertain tax positions | $ | 18,568 | | | $ | 19,030 | |
The Company’s policy is to include net interest and penalties related to unrecognized tax benefits within the provision for taxes in the Statements of Operations. The Company had approximately $0.5 million of net interest and penalties accrued at January 25, 2026.
Tax years prior to 2013 (the Company’s fiscal year 2014) are generally not subject to examination by the IRS except for items involving tax attributes that have been carried forward to tax years whose statute of limitations remains open. For state returns in the U.S., the Company is generally not subject to income tax examinations for years prior to 2012 (the Company’s fiscal year 2013). The Company has a significant tax presence in Switzerland for which Swiss tax filings have been examined through fiscal year 2020. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax examinations cannot be predicted with certainty. If any issues addressed in the Company’s tax examinations are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.
Cash Taxes Paid
The Company adopted ASU 2023-09 and has included the following table as a result of the adoption. A reconciliation of the income taxes paid (net of refunds received) is as follows:
| | | | | |
| (in thousands) | January 25, 2026 |
| Federal taxes | $ | (997) | |
| State taxes | 439 | |
| Foreign taxes: | |
| Australia | 5,546 | |
| France | (1,199) | |
| Hong Kong | 457 | |
| India | 1,065 | |
| Japan | 242 | |
| Mexico | 317 | |
| Sweden | 1,176 | |
| Switzerland | 359 | |
| UK | (3,806) | |
| Other Foreign | 477 | |
| Total cash taxes paid | $ | 4,076 | |
Note 12: Leases
The Company has operating leases for real estate, vehicles and office equipment, which are accounted for in accordance with ASC 842, "Leases." Real estate leases are used to secure office space for the Company's administrative, engineering, production support and manufacturing activities. The Company's leases have remaining lease terms of up to eight years, some of which include options to extend the leases for up to five years, and some of which include options to terminate the leases within one year.
The components of lease expense were as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Operating lease cost | $ | 7,273 | | | $ | 7,278 | |
| Short-term lease cost | 65 | | | 219 | |
| | | |
| Less: sublease income | (522) | | | (552) | |
| Total lease cost | $ | 6,816 | | | $ | 6,945 | |
Supplemental cash flow information related to leases was as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Cash paid for amounts included in the measurement of lease liabilities | $ | 7,878 | | | $ | 7,899 | |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 7,180 | | | $ | 3,509 | |
| | | |
| | | | | |
| |
| January 25, 2026 |
| Weighted-average remaining lease term - operating leases (in years) | 4.8 |
| Weighted-average discount rate on remaining lease payments - operating leases | 6.9 | % |
Supplemental balance sheet information related to leases was as follows:
| | | | | | | | | | | |
| |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Operating lease right-of-use assets in "Other Assets" | $ | 23,455 | | | $ | 21,729 | |
| | | |
| Operating lease liabilities in "Accrued Liabilities" | $ | 6,063 | | | $ | 6,006 | |
| Operating lease liabilities in "Other long-term Liabilities" | 20,697 | | | 18,502 | |
| Total operating lease liabilities | $ | 26,760 | | | $ | 24,508 | |
Maturities of lease liabilities as of January 25, 2026 are as follows:
| | | | | |
| (in thousands) | |
| Fiscal Year Ending: | |
| 2027 | $ | 7,649 | |
| 2028 | 7,075 | |
| 2029 | 5,964 | |
| 2030 | 4,066 | |
| 2031 | 3,489 | |
| Thereafter | 3,438 | |
| Total lease payments | 31,681 | |
| Less: imputed interest | (4,921) | |
| Total | $ | 26,760 | |
Note 13: Commitments and Contingencies
Unconditional Purchase Commitments
The following table presents the Company’s open capital commitments and other open purchase commitments for the purchase of plant, equipment, raw material, supplies and services as of January 25, 2026:
| | | | | | | | | | | | | | | | | |
| (in thousands) | Less than 1 year | | 1-3 years | | Total |
| Open capital purchase commitments | $ | 5,812 | | | $ | 250 | | | $ | 6,062 | |
| Other open purchase commitments | 360,821 | | | 47,255 | | | 408,076 | |
| | | | | |
| Total purchase commitments | $ | 366,633 | | | $ | 47,505 | | | $ | 414,138 | |
Legal Matters
From time to time, the Company is involved in various claims, litigation, and other legal actions that are normal to the nature of its business, including with respect to intellectual property, contract, product liability, employment, and environmental matters. In accordance with ASC 450-20, "Loss Contingencies," the Company accrues an undiscounted liability for those contingencies where the incurrence of a loss is probable and the amount can be reasonably estimated. The Company also discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if material and if the amount can be reasonably estimated. The Company does not record liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated, or when the liability is believed to be only reasonably possible or remote. However, for liabilities that are reasonably possible but not probable, the Company discloses the amount of reasonably possible loss or range of reasonably possible loss, if material and if the amount can be reasonably estimated. The Company evaluates, at least quarterly, developments in its legal matters that could affect the amount of liability that has been previously accrued, and makes adjustments as appropriate. Significant judgment is required to determine both probability and the estimated amount. The Company may be unable to estimate a possible loss or range of possible loss due to various reasons, including, among others: (i) if the damages sought are indeterminate, (ii) if the proceedings are in early stages, (iii) if there is uncertainty as to the outcome of pending appeals, motions or settlements, (iv) if there are significant factual issues to be determined or resolved, and (v) if there are novel or unsettled legal theories presented. In such instances, there is considerable uncertainty regarding the ultimate resolution of such matters, including a possible eventual loss, if any.
Because the outcomes of litigation and other legal matters are inherently unpredictable, the Company's evaluation of legal matters or proceedings often involves a series of complex assessments by management about future events and can rely heavily on estimates and assumptions. While the consequences of certain unresolved matters and proceedings are not presently determinable, and an estimate of the probable and reasonably possible loss or range of loss for such proceedings cannot be reasonably made, an adverse outcome from such proceedings could have a material adverse effect on the Company's financial condition and results of operations in any given reporting period. In the opinion of management, after consulting with legal counsel, any ultimate liability related to current outstanding claims and lawsuits, individually or in the aggregate, is not expected to have a material adverse effect on the Company's financial condition, results of operations or cash flows. However, legal matters are inherently unpredictable and subject to significant uncertainties, some of which are beyond the Company's control.
As such, even though the Company intends to vigorously defend itself with respect to its legal matters, there can be no assurance that the final outcome of these matters will not materially and adversely affect the Company's business, financial condition, operating results, or cash flows.
On March 25, 2022, Harman Becker Automotive Systems GmbH and several of its affiliates (collectively "Harman") filed a complaint against certain Sierra Entities in the District Court of Munich, Germany. Harman asserted claims that the Sierra Entities, in connection with the delivery of certain modules by the Sierra Entities, violated a frame supply agreement, a quality assurance agreement and the United Nations Convention on Contracts for the International Sales of Goods. Harman alleged that it incurred approximately $16 million in damages and costs, the bulk of which amount related to settling with a customer that had to implement a firmware update provided by Sierra Entities' supplier in late 2018, before Sierra Wireless disposed of the automotive business, to address the alleged product defect. At this stage, the Company is unable to form a conclusion as to the likelihood of an unfavorable outcome or an estimate of the amount or range of any possible loss resulting from the alleged claims. The Company intends to defend the claims vigorously.
On February 20, 2025, February 25, 2025 and March 7, 2025, three Company stockholders filed separate, but substantively identical, putative class action complaints against the Company and certain of its current officers, Hong Q. Hou and Mark Lin, in the U.S. District Court for the Central District of California on behalf of persons and entities that purchased or otherwise acquired Company securities between August 27, 2024 and February 7, 2025. On June 9, 2025, the court entered an order consolidating the three actions (the "Securities Action"), appointing Luis Collazos as Lead Plaintiff, and Block & Leviton, LLP as Lead Counsel. On July 14, 2025, Lead Plaintiff filed a consolidated putative class action complaint (the "Consolidated
Complaint") against the Company, Hou and Lin, on behalf of persons and entities that purchased or otherwise acquired Company securities between October 10, 2024 and February 7, 2025. The Consolidated Complaint asserts Exchange Act violations related to the Company’s disclosure surrounding its CopperEdgeTM products. Lead Plaintiff seeks compensatory damages and other relief. The Company, Hou and Lin filed a motion to dismiss the Consolidated Complaint on August 11, 2025, which the Court granted in part, and denied in part on October 8, 2025. By virtue of the ruling, Lin is no longer a defendant. On February 6, 2026, the Leading Plaintiff filed a motion for class certification for the period November 25, 2024 to February 7, 2025. At this stage, the Company is unable to form a conclusion as to the likelihood of an unfavorable outcome or an estimate of the amount or range of any possible loss resulting from the alleged claims.
On May 9, 2025 and August 12, 2025, other Company stockholders filed separate derivative actions in the U.S. District Court for the Central District of California against certain of the Company's directors and officers. On June 6, 2025 and November 24, 2025, other Company stockholders filed separate derivative actions in the Superior Court of the State of California for the County of Ventura against certain of the Company's directors and officers, (together with the complaints filed in federal court, the "Derivative Actions"). The Derivative Actions assert breach of fiduciary duty and other claims based on factual allegations similar to those raised in the Securities Action. The plaintiffs in the Derivative Actions seek damages payable to the Company and declaratory, injunctive and other relief.
Environmental Matters
The Company vacated a former facility in Newbury Park, California in 2002, but continues to address groundwater and soil contamination at the site. The Company’s efforts to address site conditions have been at the direction of the Los Angeles Regional Water Quality Control Board ("RWQCB"). In October 2013, an order was issued including a scope of proposed additional site work, monitoring and remediation activities. The Company has been complying with RWQCB orders and direction, and continues to implement an approved remedial action plan addressing the soil, groundwater and soil vapor at the site.
The Company has accrued liabilities where it is probable that a loss will be incurred and the cost or amount of loss can be reasonably estimated. Based on the latest determinations by the RWQCB and the most recent actions taken pursuant to the remedial action plan, the Company estimates the total range of probable loss to be between $9.1 million and $9.4 million. To date, the Company has made $8.0 million in payments towards the remedial action plan. The estimated range of probable loss remaining as of January 25, 2026 was between $1.1 million and $1.4 million. Given the uncertainties associated with environmental assessment and the remediation activities, the Company is unable to determine a best estimate within the range of loss. Therefore, the Company has recorded the minimum amount of probable loss and as of January 25, 2026, has a remaining accrual of $1.1 million related to this matter. These estimates could change as a result of changes in planned remedial actions, further actions from the regulatory agency, remediation technology and other factors.
Indemnification
The Company has entered into agreements with its current and former executives and directors indemnifying them against certain liabilities incurred in connection with the performance of their duties. The Company’s Certificate of Incorporation and Bylaws also contain indemnification obligations with respect to the Company’s current directors and employees.
The Company is a party to a variety of agreements in the ordinary course of business under which the Company may be obligated to indemnify a third party with respect to certain matters. The impact on the Company's future financial results is not subject to reasonable estimation because considerable uncertainty exists as to the final outcome of any claims and whether claims will be made.
Product Warranties
The Company’s general warranty policy provides for repair or replacement of defective parts. In some cases, a refund of the purchase price is offered. In certain instances the Company has agreed to other or additional warranty terms, including indemnification provisions.
The product warranty accrual reflects the Company’s best estimate of probable liability under its product warranties. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated, and accrues for estimated incurred but unidentified issues based on historical experience. Historically, warranty expense and the related accrual has been immaterial to the Company’s consolidated financial statements.
Licenses
Under certain license agreements, the Company is committed to make royalty payments based on the sales of products using certain technologies. The Company recognizes royalty obligations as determinable in accordance with agreement terms.
Retirement Plans
The Company contributed $1.5 million, $0.8 million and $1.9 million in fiscal years 2026, 2025 and 2024, respectively, to a defined contribution retirement plan maintained for its employees based in the U.S. and contributed $1.5 million, $1.3 million
and $1.7 million in fiscal years 2026, 2025 and 2024, respectively, to a defined contribution plan for its employees based in Canada.
The Company has defined benefit pension plans for the employees of its Swiss subsidiaries (the "Swiss Plans"), which it accounts for in accordance with ASC 715-30, "Defined Benefit Plans – Pension." The Swiss Plans provide government-mandated retirement, death and disability benefits. Under the Swiss Plans, the Company and its employees make government-mandated minimum contributions. Minimum contributions are based on the respective employee’s age, salary and gender. As of January 25, 2026 and January 26, 2025, the Swiss Plans had an unfunded net pension obligation of approximately $2.4 million and $5.4 million, respectively, plan assets of approximately $52.3 million and $48.1 million, respectively, and projected benefit obligation of approximately $53.5 million and $52.4 million, respectively. For fiscal years 2026, 2025 and 2024, net periodic pension expense was $0.9 million, $1.1 million and $1.6 million, respectively, and contributions made by the Company were $1.9 million, $1.7 million and $1.8 million, respectively.
The Company records a post-retirement benefit for the employees of its French subsidiaries (the "French Plan"), which it accounts for in accordance with ASC 715-30. The French Plan is defined by the collective bargaining agreement of R&D, IT and consulting firms. Minimum contributions are based on the respective years of service for all permanent employees. As of January 25, 2026, the French Plan had an unfunded net pension obligation of approximately $1.8 million, plan assets of zero and a projected benefit obligation of approximately $1.8 million. As of January 26, 2025, the French Plan had an unfunded net pension obligation of approximately $1.5 million, plan assets of zero and a projected benefit obligation of approximately $1.5 million. For fiscal year 2026, net periodic pension credit was $0.1 million and contributions made by the Company was $1.2 million. For fiscal years 2025 and 2024, net periodic pension expense was $0.2 million and $0.1 million, respectively, and contributions made by the Company were $1.6 million and $0.5 million, respectively.
Deferred Compensation
The Company maintains a deferred compensation plan for certain officers and key executives that allows participants to defer a portion of their compensation for future distribution at various times permitted by the plan. This plan provides for a discretionary Company match up to a defined portion of the employee’s deferral, with any match subject to a defined vesting schedule.
Under this plan, the Company incurred, net of forfeitures, expense of $9.2 million, expense of $8.4 million and expense of $7.4 million in fiscal years 2026, 2025 and 2024, respectively. For fiscal year 2024, these amounts included a loss of $0.1 million, resulting from total return swap contracts used to hedge the market risk associated with the unfunded portion of the deferred compensation liability, which matured during fiscal year 2024. See Note 18, Derivatives and Hedging Activities, for further discussion of the Company's derivative instruments.
The Company’s liability for the deferred compensation plan is presented below:
| | | | | | | | | | | |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| Accrued liabilities | $ | 3,529 | | | $ | 2,930 | |
| Other long-term liabilities | 42,535 | | | 36,381 | |
| Total deferred compensation liabilities under this plan | $ | 46,064 | | | $ | 39,311 | |
The Company has purchased whole life insurance on the lives of certain current deferred compensation plan participants. This corporate-owned life insurance is held in a grantor trust and is intended to cover a majority of the Company’s costs of the deferred compensation plan. Changes in the cash surrender value of the corporate-owned life insurance resulted in a net gain of $7.7 million, gain of $5.3 million and gain of $4.9 million in fiscal years 2026, 2025 and 2024, respectively. The $11.2 million increase in the cash surrender value of the corporate-owned life insurance as of January 25, 2026 compared to January 26, 2025 was primarily related to an overall $7.8 million increase in market value reflected in earnings and $3.4 million premium deposited to the corporate-owned life insurance.
The cash surrender value of the Company's corporate owned life insurance is reported in "Other assets" on the Balance Sheets and was $46.2 million and $34.9 million as of January 25, 2026 and January 26, 2025, respectively.
Note 14: Concentration of Risk
The following significant customers accounted for at least 10% of the Company's net sales in one or more of the periods indicated:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(percentage of net sales) (1) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Customer A | 11% | | 10% | | * |
| Customer B | 14% | | 13% | | 10% |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
(1) In each period with an asterisk, the customer represented less than 10% of the Company's net sales.
The following table shows the customers that have an outstanding receivable balance that represents at least 10% of the Company's total net receivables as of one or more of the dates indicated:
| | | | | | | | | | | |
(percentage of net receivables) (1) | January 25, 2026 | | January 26, 2025 |
| Customer A | 13% | | * |
| Customer B | 12% | | 12% |
| Customer C | 12% | | 12% |
| | | |
| Customer D | 10% | | * |
| | | |
(1) In each period with an asterisk, the customer represented less than 10% of the Company's net receivables.
For fiscal years 2026, 2025 and 2024, authorized distributors accounted for approximately 74%, 72% and 66%, respectively, of the Company’s net sales. Generally, the Company does not have long-term contracts with its distributors and most can terminate their agreement with little or no notice. For fiscal year 2026, the Company's largest distributors were based in Asia.
Outside Subcontractors and Suppliers
The Company relies on a limited number of third-party subcontractors and suppliers for the supply of silicon wafers, chipsets and other electronic components, and for product manufacturing, packaging, testing and certain other tasks. Disruption or termination of supply sources or subcontractors have delayed and could in the future delay shipments and could have a material adverse effect on the Company. Although there are generally alternate sources for these materials and services, qualification of the alternate sources could cause delays sufficient to have a material adverse effect on the Company. A significant amount of the Company’s third-party subcontractors and suppliers, including third-party foundries that supply silicon wafers, are located in the U.S., China, Israel, Japan, Taiwan and Vietnam. A significant amount of the Company’s assembly and test operations are conducted by third-party contractors in China, Malaysia, Taiwan and Vietnam.
Note 15: Segment Information
The Company’s Chief Executive Officer functions as the chief operating decision maker ("CODM"). The CODM makes operating decisions and assesses performance based on the net sales and gross profit of the Company's major product lines, which represent its operating segments, to allocate resources (including employees, property, and financial or capital resources) for each segment predominantly in the annual budget and forecasting process. As discussed in Note 7, Goodwill and Intangible Assets, the Company currently has three operating segments—SIP, AMW, and ISC—that represent three separate reportable segments. The SIP reportable segment consists of a portfolio of optical and copper data communications and video transport products used in a wide variety of infrastructure and industrial applications. The AMW reportable segment provides infrastructure, industrial and high-end customers with high-performance protection devices and a portfolio of specialized radio frequency products. The ISC reportable segment provides industrial customers with an IoT solutions portfolio that includes a wide range of modules, gateways, routers, and connected services.
The Company’s assets are commingled among the various operating segments and the CODM does not use asset information in making operating decisions or assessing performance. Therefore, the Company has not included asset information by reportable segment in the segment disclosures below.
Net sales and gross profit by reportable segment were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended January 25, 2026 |
| (in thousands) | Signal Integrity | | Analog Mixed Signal and Wireless | | Total Semiconductor Products | | IoT Systems and Connectivity | | Unallocated(1) | | Total |
| Net sales | $ | 322,608 | | | $ | 373,444 | | | $ | 696,052 | | | $ | 353,923 | | | $ | — | | | $ | 1,049,975 | |
| Segment cost of sales | 112,261 | | | 153,458 | | | 265,719 | | | 228,180 | | | 13,932 | | | 507,831 | |
| Segment gross profit | $ | 210,347 | | | $ | 219,986 | | | $ | 430,333 | | | $ | 125,743 | | | $ | (13,932) | | | $ | 542,144 | |
| | | | | | | | | | | |
| Segment gross margin | 65.2 | % | | 58.9 | % | | 61.8 | % | | 35.5 | % | | NM(2) | | |
| Gross margin | | | | | | | | | | | 51.6 | % |
(1) Unallocated includes share-based compensation, and amortization of acquired technology
(2) Not meaningful
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended January 26, 2025 |
| (in thousands) | Signal Integrity | | Analog Mixed Signal and Wireless | | Total Semiconductor Products | | IoT Systems and Connectivity | | Unallocated(1) | | Total |
| Net sales | $ | 261,747 | | | $ | 322,899 | | | $ | 584,646 | | | $ | 324,641 | | | $ | — | | | $ | 909,287 | |
| Segment cost of sales | 99,091 | | | 143,527 | | | 242,618 | | | 197,080 | | | 13,061 | | | 452,759 | |
| Segment gross profit | $ | 162,656 | | | $ | 179,372 | | | $ | 342,028 | | | $ | 127,561 | | | $ | (13,061) | | | $ | 456,528 | |
| | | | | | | | | | | |
| Segment gross margin | 62.1 | % | | 55.6 | % | | 58.5 | % | | 39.3 | % | | NM(2) | | |
| Gross margin | | | | | | | | | | | 50.2 | % |
(1) Unallocated includes share-based compensation, and amortization of acquired technology
(2) Not meaningful
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended January 28, 2024 |
| (in thousands) | Signal Integrity | | Analog Mixed Signal and Wireless | | Total Semiconductor Products | | IoT Systems and Connectivity | | Unallocated(1) | | Total |
| Net sales | $ | 177,033 | | | $ | 260,264 | | | $ | 437,297 | | | $ | 431,461 | | | $ | — | | | $ | 868,758 | |
| Segment cost of sales | 75,788 | | | 113,666 | | | 189,454 | | | 249,956 | | | 133,098 | | | 572,508 | |
| Segment gross profit | $ | 101,245 | | | $ | 146,598 | | | $ | 247,843 | | | $ | 181,505 | | | $ | (133,098) | | | $ | 296,250 | |
| | | | | | | | | | | |
| Segment gross margin | 57.2 | % | | 56.3 | % | | 56.7 | % | | 42.1 | % | | NM(2) | | |
| Gross margin | | | | | | | | | | | 34.1 | % |
(1) Unallocated includes share-based compensation, and amortization of acquired technology
(2) Not meaningful
Geographic Information
Net sales activity by geographic region was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Year Ended |
| (in thousands, except percentages) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Asia-Pacific | $ | 697,597 | | | 67 | % | | $ | 574,710 | | | 64 | % | | $ | 505,603 | | | 58 | % |
| North America | 231,877 | | | 22 | % | | 204,479 | | | 22 | % | | 237,132 | | | 27 | % |
| Europe | 120,501 | | | 11 | % | | 130,098 | | | 14 | % | | 126,023 | | | 15 | % |
| | | | | | | | | | | |
| Total net sales | $ | 1,049,975 | | | 100 | % | | $ | 909,287 | | | 100 | % | | $ | 868,758 | | | 100 | % |
The Company attributes sales to a geography based on the ship-to address. The table below summarizes sales activity to geographies that represented greater than 10% of total sales for at least one of the periods presented:
| | | | | | | | | | | | | | | | | |
| | Fiscal Year Ended |
| (percentage of total net sales) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| China (including Hong Kong) | 47 | % | | 43 | % | | 32 | % |
| United States | 18 | % | | 21 | % | | 24 | % |
| Total net sales | 65 | % | | 64 | % | | 56 | % |
Although a large percentage of the Company's products is shipped into the Asia-Pacific region, a significant number of the products produced by these customers and incorporating the Company's semiconductor products are then sold outside this region.
Long-lived Assets
The following table summarizes the Company's long-lived assets, which consist of property, plant and equipment, net of accumulated depreciation, classified by location:
| | | | | | | | | | | |
| Balance as of |
| (in thousands) | January 25, 2026 | | January 26, 2025 |
| United States | $ | 52,217 | | | $ | 58,395 | |
| Rest of North America | 32,539 | | | 41,445 | |
| Europe | 13,915 | | | 14,604 | |
| Asia and all others | 10,674 | | | 11,746 | |
| | | |
| Total | $ | 109,345 | | | $ | 126,190 | |
Some of these assets are at locations owned or operated by the Company’s suppliers. The Company has consigned certain equipment to a foundry based in China to support its specialized processes run at the foundry. The Company has also installed its own equipment at some of its packaging and testing subcontractors in order to ensure a certain level of capacity, assuming the subcontractor has ample employees to operate the equipment.
The net book value of equipment and machinery that were consigned to multiple foundries in China was $2.0 million and $3.6 million as of January 25, 2026 and January 26, 2025, respectively. The net book value of equipment and machinery that were consigned to a foundry in Malaysia was $1.3 million and $1.8 million as of January 25, 2026 and January 26, 2025, respectively.
Note 16: Restructuring
From time to time, the Company takes steps to realign the business to focus on high-growth areas, provide customer value and make the Company more efficient. As a result, the Company has re-aligned resources and infrastructure, which resulted in restructuring charges related to one-time employee termination benefits of $4.2 million in fiscal year 2026 and $4.9 million in fiscal year 2025. The Company had restructuring charges of $24.6 million in fiscal year 2024, which resulted from the realization of synergies of the Sierra Wireless Acquisition. The Company also implemented a separate reduction in workforce plan that commenced during the second quarter of fiscal year 2024 and was substantially completed during the third quarter of fiscal year 2024. Additionally, the Company had $3.9 million of right-of-use asset impairments related to abandonments in fiscal year 2024. Restructuring related liabilities are included in "Accrued liabilities" in the Balance Sheets.
Restructuring activity is summarized as follows:
| | | | | | | | | | | | | | | | | |
| (in thousands) | One-time employee termination benefits | | Other restructuring | | Total |
| Balance at January 29, 2023 | $ | 4,027 | | | $ | 12 | | | $ | 4,039 | |
Charges (1) | 17,793 | | | 6,841 | | | 24,634 | |
| Cash payments and non-cash releases | (16,021) | | | (6,375) | | | (22,396) | |
| Balance at January 28, 2024 | 5,799 | | | 478 | | | 6,277 | |
Charges | 4,836 | | | 108 | | | 4,944 | |
| | | | | |
| Cash payments and non-cash releases | (9,848) | | | (586) | | | (10,434) | |
| Balance at January 26, 2025 | 787 | | | — | | | 787 | |
Charges | 4,165 | | | 21 | | | 4,186 | |
| Cash payments and non-cash releases | (4,255) | | | (21) | | | (4,276) | |
| Balance at January 25, 2026 | $ | 697 | | | $ | — | | | $ | 697 | |
(1) Restructuring charges include $6.0 million during fiscal year 2024 related to the reduction in workforce plan that commenced during the second quarter of fiscal year 2024 and was completed during the second half of fiscal year 2024.
Restructuring charges were included in the Statements of Operations as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| (in thousands) | January 25, 2026 | | January 26, 2025 | | January 28, 2024 |
| Cost of sales | $ | — | | | $ | — | | | $ | 859 | |
| | | | | |
| | | | | |
| Restructuring | 4,186 | | | 4,944 | | | 23,775 | |
Total restructuring charges (1) | $ | 4,186 | | | $ | 4,944 | | | $ | 24,634 | |
(1) Restructuring charges include $6.0 million during fiscal year 2024 related to the reduction in workforce plan that commenced during the second quarter of fiscal year 2024 and was completed during the second half of fiscal year 2024.
Note 17: Common Stock
Secondary Public Offering
On December 9, 2024, the Company closed a secondary public offering of 10,496,032 shares of its common stock for gross proceeds of $661.0 million. The Company received net proceeds of $640.7 million after deducting underwriters' discounts and other offering related expenses. The net proceeds from the secondary public offering were used to repay amounts outstanding on our Revolving Credit Facility and our Term Loans. For additional information, see Note 9, Long-Term Debt, to our Consolidated Financial Statements.
Stock Repurchase Program
The Company maintains a stock repurchase program that was initially approved by its board of directors (the "Board of Directors") in March 2008. The stock repurchase program does not have an expiration date and the Board of Directors has authorized expansion of the program over the years. On March 11, 2021, the Board of Directors approved the expansion of the stock repurchase program by an additional $350.0 million. As of January 25, 2026, the remaining authorization under the program was $209.4 million. Under the program, the Company may repurchase its common stock at any time or from time to time, without prior notice, subject to market conditions and other considerations. The Company’s repurchases may be made through Rule 10b5-1 and/or Rule 10b-18 or other trading plans, open market purchases, privately negotiated transactions, block purchases or other transactions. To the extent the Company repurchases any shares of its common stock under the program in the future, the Company expects to fund such repurchases from cash on hand and borrowings on its Revolving Credit Facility. The Company has no obligation to repurchase any shares under the program and may suspend or discontinue it at any time.
There were no shares repurchased under the stock repurchase program in fiscal years 2026, 2025, and 2024.
Note 18: Derivatives and Hedging Activities
The Company is exposed to certain risks arising from both its business operations and economic conditions and principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company, on a routine basis and in the normal course of business, experiences expenses denominated in Swiss Franc ("CHF"), Canadian Dollar ("CAD") and Great British Pound ("GBP"). Such expenses expose the Company to exchange rate fluctuations between these foreign currencies and USD. The Company occasionally uses derivative financial instruments, in the form of forward contracts, to mitigate a portion of the risk associated with adverse movements in these foreign currency exchange rates during a twelve-month window. Currency forward contracts involve fixing the exchange rate for delivery of a specified amount of foreign currency on a specified date. The Company’s accounting treatment for these instruments is based on whether or not the instruments are designated as a hedging instrument. The Company applied hedge accounting to all foreign currency derivatives and designated these hedges as cash flow hedges.
The Company's foreign currency forward contracts had the following outstanding balances:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Balance as of |
| | January 25, 2026 | | January 26, 2025 |
| (in thousands, except number of instruments) | | Number of Instruments | | Sell Notional Value | | Buy Notional Value | | Number of Instruments | | Sell Notional Value | | Buy Notional Value |
| Sell USD/Buy CAD Forward Contract | | 24 | | $ | 32,270 | | | $ | 44,250 | | | 0 | | $ | — | | | $ | — | |
| Sell USD/Buy CHF Forward Contract | | 24 | | 8,868 | | | Fr. | 6,900 | | | 0 | | — | | | Fr. | — | |
| Sell USD/Buy GBP Forward Contract | | 24 | | 13,666 | | | £ | 10,100 | | | 0 | | — | | | £ | — | |
| Total | | 72 | | | | | | 0 | | | | |
These foreign currency forward contracts were designated as cash flows hedges and the unrealized gains or losses, net of tax, were recorded as a component of "Accumulated other comprehensive income or loss" ("AOCI") in the Balance Sheets. The effective portions of the cash flow hedges were recorded in AOCI until the hedged items were recognized in either "Selling, general and administrative expense" or "Product development and engineering expense" in the Statements of Operations once the foreign exchange contract matured, offsetting the underlying hedged expenses. Any ineffective portions of the cash flow hedges were recorded in "Non-operating income, net" in the Statements of Operations. The Company presents its derivative assets and liabilities at their gross fair values in the Balance Sheets.
In the first quarter of fiscal year 2024, the Company entered into an interest rate swap agreement with a 2.75 year term to hedge the variability of interest payments on $150.0 million of debt outstanding on the Term Loans at a Term SOFR rate of 3.58%, plus a variable margin and spread based on the Company’s consolidated leverage ratio. This interest rate swap agreement was partially terminated in the second quarter of fiscal year 2026 and fully terminated in the third quarter of fiscal year 2026.
In the fourth quarter of fiscal year 2023, the Company entered into an interest rate swap agreement with a 5 year term to hedge the variability of interest payments on $450.0 million of debt outstanding on the Term Loans at a Term SOFR rate of 3.44%, plus a variable margin and spread based on the Company’s consolidated leverage ratio. This interest rate swap agreement was terminated in the fourth quarter of fiscal year 2025 due to partial repayment of the Term Loans.
In the first quarter of fiscal year 2021, the Company entered into an interest rate swap agreement with a 3 year term to hedge the variability of interest payments on the first $150.0 million of debt outstanding under the Company's Revolving Credit Facility at a LIBOR-referenced rate of 0.73%, plus a variable margin and spread based on the Company's consolidated leverage ratio. This interest rate swap agreement matured during the first quarter of 2024.
The interest rate swap agreements have been designated as a cash flow hedges and unrealized gains or losses, net of income tax, are recorded as a component of AOCI in the Balance Sheets. As the various settlements are made on a monthly basis, the realized gain or loss on the settlements are recorded in "Interest expense" in the Statements of Operations. The interest rate swap agreements resulted in a realized gain of $0.2 million, gain of $9.2 million and gain of $10.2 million for fiscal years 2026, 2025 and 2024, respectively.
The fair values of the Company's instruments that qualify as cash flow hedges in the Balance Sheets were as follows: | | | | | | | | | | | | | | |
| (in thousands) | | January 25, 2026 | | January 26, 2025 |
| Interest rate swap agreement | | $ | — | | | $ | 745 | |
| Foreign currency forward contracts | | 474 | | | — | |
| Total other current assets | | $ | 474 | | | $ | 745 | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |